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Abstract: In the review, the nature of protein multifunctionality is analyzed. In the ﬁ  rst part of the review the principles of 
structural/functional organization of protein are discussed. In the second part, the main mechanisms involved in develop-
ment of multiple functions on a single gene product(s) are analyzed. The last part represents a number of examples showing 
that multifunctionality is a basic feature of biologically active proteins.
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I. Main Principles of Protein Organization: Structural Compactness
and Functional Variability
1. General consideration on the factors determining protein multifunctionality
The cell fulﬁ  lls two main functions: (1) storage of genetic information and transfer it to the next cell 
generation; (2) synthesis of different molecules, protein molecules in particular, for fulﬁ  llment of numer-
ous cell processes.
The compactness (maximum information packed in minimum DNA space) is one of the main prin-
ciples of genetic information storage. The fulﬁ  llment of the ﬁ  rst cell function is based on this principle. 
On the contrary, the abundance, variability and diversity of the protein molecules are necessary for 
realization of the second function. In contrast to DNA, proteins exhibit an apparently unlimited variety 
of structure. This is a necessary requirement of the vast array of different functions that they perform 
in maintenance of life “in contrast to the relatively static archival function of DNA” (Lesk, 2001). 
In the protein world, not only “a bewildering variety of form is observed but even within a common 
structure, there is variation in the lengths and orientation of substructures. Such variation is both a 
reﬂ  ection of the very long evolution of protein structures and also a consequence of the fact that proteins 
cannot be completely rigid bodies but must have ﬂ  exibility to accommodate the structural changes that 
are almost always necessary for them to perform their functions” (Lesk, 2001).
All multiple variations in protein structures and functions are genetically determined by DNA sequence 
ﬁ  xed in amino acid primary structure of a protein and can be achieved by different mechanisms operat-
ing at different levels.
At the level of genome, a single gene may undergo duplication followed by rearrangement and/or 
mutations thus leading to appearance of homologous proteins possessing partially similar and/or dif-
ferent functions (Fig. 1, A).
At the next level of variability and complexity, transcriptome level, the gene transcription can be 
altered by several mechanisms including usage of alternative promoters, different transcription initia-
tion sites, mRNA splicing and mRNA stability (Fig. 1, B). The extent of variability that may be obtained 
by mRNA alternative splicing is almost unlimited. An exelent example of this statement is the Dro-
sophila gene Dscam, encoding Down syndrome cell-adhesion protein. Althernative splicing of Dscam 
pre-mRNA potentially generates 38 016 isoforms of a cell-surface recognition protein (Schmucker et al. 
2000; Zipursky et al. 2006).
Further complexity is observed at the proteome level. A variety of the protein products encoded by 
the same gene can be achieved by three groups of speciﬁ  c mechanisms: those operating at the translational 100
Zaretsky and Wreschner
Translational Oncogenomics 2008:3 
level; the mechanisms that determine post-
tranlational modiﬁ  cations and mechanisms control-
ling the intermolecular interactions. Multiple 
translation products can be synthesized by usage 
different cap-dependent and cap-independent inter-
nal ribosome entry site (IRES) determined initiation 
mechanisms (Fig. 1, C) including leaky scanning, 
ribosome-shunting, termination-initiation and mix 
(or alternative) initiation (Cai et al. 2006; Candeias 
et al. 2006; Holcik et al. 2000; Huez et al. 1998; 
Kochetov, 2006; Kozak, 2002; Lu et al. 2004; Yueh 
and Schneider, 1996). At elongation stage of protein 
synthesis, frameshifting and “hopping” (Fig. 1, D) 
also make substantial impact in protein diversity 
(Atkins et al. 2001; Herr et al. 2000b; Namy et al. 
2004). Stop codon readthrough (Fig. 1, E) is the 
main mechanism that determines appearance of 
new protein isoforms at the last stage of translation 
(Keeling et al. 2004; Namy et al. 2002).
Post-translation modiﬁ  cations of the primary 
polypeptide molecule (Fig. 1, F) include such 
mechanisms as different types of glycosylation, 
phosphorylation, acylation, specific restricted 
proteolysis, protein splicing and many others 
(Hanada et al. 2004; Rehfeld and Goetze, 2003). 
The intermolecular interactions that modify protein 
properties and functions occur between protein and 
metal, protein and carbohydrate, protein and lipid 
and protein and protein. These interactions lead to 
multiple folding variants which in their turns deter-
mine topology and functions of multiple products 
encoded by one and the same gene.
It is important to underline once again that all 
possible modiﬁ  cations and interactions of a given 
gene product(s) are encoded in its nucleotide 
sequence and, as a consequence, in amino acid 
structure of polypeptide molecule(s). The reactions 
described above are based on the natural mecha-
nisms by which condensed genetic information can 
be transformed into variable and multiple protein 
structures and functions.
The wisdom of Nature [G-d] is that it does not 
create anything without speciﬁ  c purpose. There is 
nothing in nature what is superﬂ  uous or unneces-
sary. This is the main principle of nature. If amino 
acid sequence of a protein contains genetically 
determined possibilities for any type of modiﬁ  ca-
tions (by proteolysis, folding, glycosylation, phos-
phorylation etc), there should be deﬁ  nite conditions 
in a deﬁ  nite cell or tissue in an appropriate point 
of time which would allow realization of the 
encoded modiﬁ  cations.
Although the principle of structural and func-
tional compactness is the most evident in nucleic 
acids, it would be mistake to think that this prin-
ciple does not work in protein molecules. Actually, 
the genetic information contained in the DNA 
sequence is realized in two ways: each protein 
molecule produced by a gene contains maximum 
of functional possibilities, and each gene produces 
as much protein molecules as necessary for per-
forming all functions encoded by the gene. These 
principles lead to multifunctionality of protein 
molecules. The following example from the virus 101
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Figure 1. Mechanisms involved in development of protein multifunctionality. Mechanisms operating at genome (A), transcriptome (B), 
proteome (C-E) and post-translational (F) levels.104
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world may illustrate this idea. Owing to the small 
size of their genome, viruses have evoleved by 
packing a maximum of genetic information in a 
minimum of polypeptide sequence. As a conse-
quence, many of the proteins or protein domains 
encoded by viruses are multifunctional. The trans-
membrane (TM) domains of Hepatitis C Virus 
envelope glycoprotein are extreme examples of 
such multifunctionality. Indeed, these TM domains 
bear ER retention signals, demonstrate signal func-
tion and are involved in E1:E2 heterodimerization 
(Cocquerel et al. 1999; Cocquerel et al. 1998; 
Cocquerel et al. 2000). All these functions are 
partially overlapped and present in the sequence 
of 30 amino acids thus evidently demonstrating 
the principle of structure/functional compactness 
reﬂ  ected in protein structure as well as in its func-
tional map (Cocquerel et al. 2002).
2. Hierarchical nature of protein architecture
For better understanding ability of a protein to 
develope multiple functions and to discover poten-
tials hidden in protein molecule, one should get 
insight the hierarchical nature of protein architec-
ture. As pointed out by A. Lesk, several hierarhial 
levels of structural complexity can be observed in 
protein molecules (Lesk, 2001):
1. The  ﬁ  rst level is the sequence of amino acids in 
a polypeptide (primary structure).
2.  The assignment of α-helices and β-sheets is the 
hydrogen-bonding pattern of the main polypep-
tide chain (secondary structure). This is the 
second level of complexity. Many proteins 
demonstrate recurrent patterns of interaction 
between helices and sheets present in one poly-
peptide molecule. These interactions form 
supersecondary structure.
3. The most of the protein molecules contain 
compact units within the folding patterns of a 
single chain, domains, that demonstrate deﬁ  nite 
structural stability and functional indepen-
dence. Protein domains can be deﬁ  ned as seg-
mented portions of a polypeptide sequence that 
assume stable three-dimensional structure 
(Richardson, 1981; Wriggers et al. 2005). A 
domain usually fulﬁ  lls speciﬁ  c function(s). 
Assembly of domains and intervaining ﬂ  exible 
stretches of short peptide chains develops mul-
tidomain protein molecule characterized by the 
tertiary structure (the third level of structural 
complexity).
4. Within multidomain proteins, each domain is 
capable of autonomous function, however, some 
of them also mediate the formation of com-
plexes with partner proteins (intermolecular 
interactions) giving rise for new functions and 
forming so called a domain network (Santonico 
et al. 2005). The multidomain proteins contain-
ing more than one polypeptide chain compose 
the assembly of the monomers that represents 
the fourth level of complexity—the quaternary 
structure.
Multidomain proteins containing several copies 
of closely related domains are so called modular 
proteins. The modular protein can “mix and match” 
sets of domains. For example, ﬁ  bronectin, a large 
extracellular protein, contains 29 domains includ-
ing multiple tandem repeats of three types of 
domains, F1, F2 and F3 (Lesk, 2001). These and 
many other domains such as EGF, Ig, PZS etc are 
integral parts of the multiple modular proteins. 
Such recurring protein motifs, domains, are sig-
niﬁ  cant because it is increasingly recognized that 
“there are only a limited number of domain fami-
lies in nature” (Wriggers et al. 2005). These 
domains are duplicated and combined in different 
ways to form the set of proteins (Apic et al. 
2003).
Most of the known proteins are multifunctional 
molecules. The presence in a protein molecule of 
several domains that possess different functions 
indicates on its multifunctionality. At the beginning 
of the 1990s, K. Mizejewsky proposed the hypoth-
esis of the “modular cassette” (Dauphinee and 
Mizejewski, 2002; Mizejewski, 1993). According 
to this hypothesis, the presence of amino acid 
stretches (domains) in a protein that are similar to 
those in physiologically active proteins implies 
that they may have similar functions. This hypoth-
esis allows prediction of functional activities of 
newly discovered proteins or proteins which func-
tion have not yet been well studied. For example, 
more than 20 types of functionally important sites 
(domains) have been predicted and later on identi-
ﬁ  ed in α-fetoprotein (Terentiev and Moldogazieva, 
2006). Among these sites, there are sites respon-
sible for binding of hydrophobic ligands (metal 
ions, estrogens, bilirubin, retinoids, ﬂ  avonoids, 
exotoxins, various dyes and drugs (Aoyagi et al. 
1979; Aussel and Negrel, 1986; Birkenmeier et al. 
1983; Iturralde et al. 1991; Milligan et al. 1998; 
Nagai et al. 1982; Nishi et al. 1991; Ruiz-Gutierrez 105
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et al. 2001; Ruoslahti et al. 1979; Tatarinov et al. 
1991), sites that demonstrate immunosuppressive 
activity (Naval et al. 1985; Suzuki et al. 1992; 
Torres et al. 1992; Torres et al. 1989) and sites that 
regulate cell proliferation and tumor growth (Allen 
et al. 1993; Jacobson et al. 1990; Leffert and Sell, 
1974; Li et al. 2002; Mizejewski et al. 1983).
It has become clear over the past decade that 
unrelated modular proteins frequently share sig-
niﬁ  cant portions of sequence similarity (Bork et al. 
1997; Cesareni, 2004; Pawson and Nash, 2003; 
Santonico et al. 2005). Thus, a large number of 
functionally diverse proteins can be thought of as 
molecules built by combining a limited number of 
structurally stable folded domains. A good example 
of such “building bricks” is the SAM domains. The 
SMART database identiﬁ  es more than 1300 SAM-
containing proteins in genomes of all organisms 
from yeast to humans. They present in such differ-
ent proteins as protein-kinases, lipid-kinases, scaf-
folding proteins, RNA-binding proteins and 
transcription factors. Although SAM domains adopt 
similar folds, they are remarkably versatile in their 
binding properties. Some identical SAM domains 
can interact with each other to form homodimers 
or polymers. In other cases, SAM domains can bind 
to other related SAM domains, to non-SAM domain-
containing proteins, and even to RNA. Such ver-
satility earns them multiple functional roles in 
different biological processes such as signal trans-
duction, transcriptional regulation and translational 
control (Qiao and Bowie, 2005).
Speaking about protein architecture and func-
tion, it is important to underline the role which 
flexible linkers play in interconnection of the 
various domains in multidomain proteins. These 
linkers are stretches of amino acid residues that 
establish communication between different 
domains and functional modules (Gokhale and 
Khosla, 2000). A number of examples (e.g. immu-
noglobulin, diphtheria toxin, tomato bushy stunt 
virus protein) established a clear relationship 
between linker peptides and the functional dynam-
ics they enable. Conformational transitions in 
multiple identical or homologous proteins have 
been observed. This gained widespread acceptance 
to the concept of hinge-bending (Dobson, 1990), 
whereby the relative ﬂ  exibility of short regions of 
the polypeptide chain allow signiﬁ  cant movement 
of structural domains.
One important consequence of the ﬂ  exibility 
afforded by soft peptide linkers is the ability of 
linked domains to move to and from close spatial 
proximity. The ﬂ  exibility and hydrophilicity of the 
linker are important factors in preventing the dis-
turbance of the domain functions, thereby impart-
ing stability to the domains (Arai et al. 2004). A 
range of stability occurs depending on rigidity of 
the linker peptides. Soft linkers confer ﬂ  exibility, 
whereas more rigid peptides may act to keep 
domains apart (Wilchek and Miron, 1974).
Due to their ability to break or form contacts 
among adjacent domains, soft linkers often facili-
tate essential catalytic events in the overall function 
of a protein, as seen, for instance, in the tomato 
bushy stunt virus proteins (Harrison, 1981) or in 
the NFκB (Henkel et al. 1992). The hinge region 
of the NFκB is ﬂ  exible enough to bring “p50” and 
“SW16/ANK” repeat domains into contact to 
regulate intracellular transport of the transcription 
factor (Henkel et al. 1992).
The classical example of the ﬂ  exible linker 
power to produce large number of diverse func-
tional interactions using limited number of struc-
tural domains is calmodulin. Calmodulin contains 
four Ca
2+-binding domains known as the EF-hand 
with highly conserved amino acid sequences in all 
eukaryotes (Ikura and Ames, 2006; Kretsinger and 
Nockolds, 1973). Calmodulin regulates numerous 
target proteins that are functionally and structurally 
diverse. It activates cyclic nucleotide phosphodi-
esterase (Cheung, 1970; Gopinath and Vincenzi, 
1977; Kakiuchi and Yamazaki, 1970), Ca
2+-
transpotring ATPase (Gopinath and Vincenzi, 
1977; Jarrett and Penniston, 1977), phosphorylase 
kinase (Cohen et al. 1978), nitric oxide synthetase 
(Stuehr et al. 1991) and many others. The list of 
known calmodulin dependent proteins exceeds 300 
in number (Yap et al. 2000).
How calmodulin could bind and regulate all 
these different proteins? The structure determined 
for calmodulin in the complex with a target protein 
by NMR showed remarkable conformational 
change in calmodulin’s two EF-hand domains upon 
binding to the target protein (Ikura et al. 1992; 
Meador et al. 1992; Yap et al. 2000). This structure 
revealed that central domain linker is magically 
ﬂ  exible and can be bent dramatically upon binding 
to the target protein (Barbato et al. 1992; Persechini 
and Kretsinger, 1988; Trewhella, 1992). The ﬂ  ex-
ibility of the linker enables calmodulin to change 
its conformation as needed depending on the struc-
ture of target protein. Such conformational plastic-
ity of calmodulin protein allows it to gain 106
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multifunctionality: by simply connecting two 
EF-hand modules via a ﬂ  exible linker, an expo-
nential increase in the number of target interactions 
is achieved (Ikura and Ames, 2006).
II. The Basic Mechanisms 
Ensureing Transformation
of Protein Structural Pecularities 
into Functional Multiplicity
Protein structural complexity and compactness 
may be achieved by different mechanisms operat-
ing at genome, transcriptome and proteome levels 
(Fig. 1, A-E). Several examples of multifunctional 
proteins described below may demonstrate how 
multifunctionality may be developed by these 
mechanisms.
Genome level
The main tools in generation of biological diversity 
at the genome level are mutations (insertion or 
deletion of nucleotides in DNA sequences), trans-
position of pieces of DNA and gene duplication 
followed by genetic divergencies in each dupli-
cated genes. If these changes in genetic information 
induce changes in protein structure and function, 
they undergo evolutionary selection and can be 
traced phylogenically (Fig. 1, A).
1. Mutations as sources for multifunctionality
The product of the mutated gene can be “either an 
alternative protein of equivalent function -a neutral 
mutation- or a protein that carries out the same 
function but with an altered rate or speciﬁ  city 
proﬁ  le. It can be a protein with an altered function, 
or a protein that does not function—or even fold- 
at all” (Lesk, 2001). For instance, human adult and 
foetal haemoglobins differ by substitution of Ser 
(143β) for His. Primarily, as a result of this muta-
tion, foetal haemoglobin demonstrates lower 
afﬁ  ninty than adult homologue for the regulatory 
ligand diphosphoglycerate. This promotes the 
transfer of oxygen across the placenta to the foetus 
(Lesk, 2001).
Another example demonstrates role of minor 
genetic alterations in induction of fundamental 
functional changes in the homologous proteins. 
Haptoglobin is a chymotrypsin homologue. As a 
result of homologuos gene mutations, it lost pro-
teolytic activity characteristic for chymotrypsin 
but obtained several other functions: haptoglobin 
may function as chaperon as well as factor pre-
venting the loss of iron from erythrocytes and as 
protein mediating immune responses (Lesk, 
2001).
2. Gene duplication as the origin
of genetic novelties
It has been proposed that gene duplication is one 
of the important step for the origin of genetic nov-
elties (Gu et al. 2002; Ohno, 1970). The following 
examples can conﬁ  rm this proposition. GroEL is 
a 60 Kda heat-shock protein ubiquitous in bacteria. 
Interestingly, the GroEL in Chlamydiae became 
duplicated at the origin of the Chlamydiae lineage 
presenting three distinct molecular chaper-
ones, namely the original protein GroEL1, and 
its paralogous proteins GroEL2 and GroEL3 
(Karunakaran et al. 2003; McNally and Fares, 
2007). GroEL protein copies species have diverged 
functionally after the gene duplication events. The 
functional divergence has occurred in important 
functional regions of these proteins. Even though 
the three Chlamidiae GroEL proteins present sub-
stantial amino acid sequence conservation in 
important regions involved in polypeptide binding 
when compared to GroEL from the Escherichia 
coli, signiﬁ  cant differences have been spotted in 
GroEL binding regions and at regions involved in 
ATP binding and hydrolysis. Most of the amino 
acid replacements that have affected interaction 
with protein partners and were responsible for the 
functional divergence between GroEL paralogs 
were ﬁ  xed by adaptive evolution after the groEL 
gene duplication events (McNally and Fares, 
2007).
Stromal interaction molecules (STIMs) repre-
sent another example demonstrating the role of 
gene duplication in functional divergence of 
homologous proteins. STIMs function as the Ca
2+ 
sensor to detect changes of Ca
2+ content in the 
intracellular stores. STIMs are single-span mem-
brane proteins with unpaired N-terminal EF-hand 
Ca
2+ binding domain critical for Ca
2+ sensor 
function. In addition, STIMs contain an N-terminal 
sterile α motif (SAM) domain and a C-terminal 
(cytoplasmic) coiled-coil ERM domain (Liou et al. 
2005; Roos et al. 2005; Williams et al. 2001; 
Zhang et al. 2005). Human STIMs and inverte-
brate STIM share several functionally important 
protein domains, but diverge signiﬁ  cantly in the 
C-terminus.107
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The phylogeny and sequence analysis revealed 
early adaptation of the C-terminal divergent 
domain in Urochordata, before the expantion of 
STIMs in Vertebrata. STIMs were subsequently 
subjected to one round of gene duplication as early 
as in the Euteleostomi lineage in vertebrates, with 
a second round of ﬁ  sh-speciﬁ  c gene duplication. 
After duplication, STIM-1 and STIM-2 molecules 
appeared to have undergone purifying selection. 
Furthermore, sequence analysis of the EF-hand 
Ca
2+ binding domain and the SAM domain, 
together with functional studies, identiﬁ  ed critical 
regions/residues likely underlying functional 
changes and proved evidence for the hypothesis 
that STIM-1 and STIM-2 might have developed 
distinct functional properties after gene duplication 
(Cai, 2007).
Transcriptome level
Alternative splicing is a common post-transcriptional 
process in eukaryotic organisms to produce multiple 
transcript isoforms from a single gene (Black, 2003). 
Alternative splicing and gene duplication are two 
sources of proteomic functional diversity (Fig. 1, A, B). 
According to the “independent model” alternative 
splicing and gene duplication are two independent 
mechanisms for increasing the proteomic complexity. 
Alternatively, the “function-sharing model” claims 
that some proteomic components can be performed 
either by alternatively spliced genes or duplicate 
genes [cited by (Su et al. 2006)].
Alternative splicing can generate multiple tran-
scripts encoding proteins with subtle or opposing 
functional differences that may have profound 
biological consequences. Recent estimates, based 
on analyses of expressed sequence tags (ESTs), 
suggest that the transcripts from 35% of human 
genes are alternatively spliced (Hanke et al. 1999; 
Mironov et al. 1999). However, as pointed out by 
B. Graveley, “this number is likely to be an under-
estimate” (Graveley, 2001). First, the human EST 
collection does not represent all protein coding 
sequences and for most genes, ESTs cover only a 
portion of the transcript. Because much of the 
functionally signiﬁ  cant alternative splicing occurs 
in the coding region of the transcript, many alterna-
tive splicing events might be overlooked by EST 
comparisons. Second, and perhaps more important, 
many alternative splicing events are very rare and 
occur only in a speciﬁ  c tissue at a speciﬁ  c time in 
development and/or under certain physiological 
conditions. These types of splicing events will 
probably not be represented in EST collections 
(Graveley, 2001). Some genes produce several 
spliced mRNAs while it turns out that some other 
genes, in fact, encode transcripts that are alterna-
tively spliced to produce tens of thousands of dif-
ferent mRNAs (Schmucker et al. 2000).
The neurexin proteins represent an example 
which demonstrates the role of alternative splicing 
in obtaining different functions by one gene prod-
ucts. The neurexins are a family of neural proteins 
present in vertebrates that have important functions 
as receptors for neuropeptides (Missler and Sudhof, 
1998) and as adhesion molecules that participate 
in synaptogenesis (Scheiffele et al. 2000). It has 
been shown that more than 1000 different neurexin 
mRNA isoforms could potentially be synthesized 
virtue of alternative promoter usage and alternative 
splicing (Ullrich et al. 1995). The proteins encoded 
by these alternative spliced mRNA have altered 
speciﬁ  cities for their ligands (Ichtchenko et al. 
1995; Sugita et al. 1999). Beside that, the diversity 
of neuroxin proteins might specify neural connec-
tivity (Missler et al. 1998). It has been shown that 
interaction of β-neurexins present in pre-synaptic 
cells with neuroligins on the surface of post-synaptic 
cells is sufficient to trigger synapse formation 
(Scheiffele et al. 2000). Importantly, this interac-
tion only occurs if the β-neurexin is encoded by an 
mRNA lacking an alternative exon 20. Proteins 
synthesized from exon 20-containing transcripts do 
not interact with neuroligins (Ichtchenko et al. 
1995). Thus, alternative splicing of the neurexin 
transcripts might have a direct role in controlling 
the formation and maintenance of synapses.
Proteome level
Proteome is a set of proteins obtained by translation 
of mRNAs exported from nucleus to cytoplasm. 
Translation of mRNA into protein represents the 
ﬁ  nal step in the gene-expression pathway, which 
mediates the formation of the proteome from 
genomic information (Gebauer and Hentze, 2004). 
As we have already underlined, at the genome 
level, the maximal volume of genetic information 
has to be encoded in minimal DNA space. At tran-
scriptome level, the consealed diversity of future 
proteins encoded in DNA and mRNA is revealed 
by shufﬂ  ing of different fragments of the primary 
transcript during the alternative splicing process. 
The alternative promoter usage in its turn discloses 108
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the diversity of genetic information contained in 
mRNA and destined for translation. At the pro-
teome level, the maximum of structural and func-
tional potentials contained in the genetic 
information embeded in mRNA can be elicited by 
translational mechanisms. Recent data obtained by 
sequencing of the human genome showed that the 
human genome composed of about 35 000 genes 
which may express about 100 000 proteins. Such 
protein outburst is possible only because numerous 
mechanisms exist by which functionally diverse 
polypeptides are produced from a single gene 
(Touriol et al. 2003).
The ability to produce different polypeptides by 
translation of one and the same mRNA molecule 
is installed in the translation mechanism by itself. 
Conceptually, the translation process can be 
divided into three stages—initiation, elongation 
and termination. During initiation the ribosome is 
reassembled on mRNA, with initiator tRNA bound 
in the ribosomal P site and base paired with the 
start codon of the mRNA. Elongation refers to the 
polymerization of the peptide, the main function 
of the ribosome, while termination includes the 
sequence of events following recognition of the 
stop codon up to the disassembly of the ribosome 
into subunits and subsequent dissociation of the fac-
tors, tRNA, and mRNA (Touriol et al. 2003). The 
mechanisms operating at each stage determine the 
appearance of different isoforms of one and the 
same gene product (Fig. 1, C-E).
A. Initiation stage
1. Cap-dependent initiation
Translation initiation of eukaryotic mRNAs in 
general occurs by a scanning mechanism (Kozak, 
2002). According to the linear scanning model, 
40S ribosomal subunit binds to the cap structure 
(m7GpppN) at the 5’ end of mRNA and scanning 
downstream to the ﬁ  rst in frame AUG initiation 
codon (Pestova and Hellen, 1999). The canonical 
scanning mechanisms (Fig. 1, C1) rules initiation 
of most mRNAs, but three non-classical cap-
dependent initiation mechanisms have been also 
described: leaky scanning, ribosomal shunting and 
termination initiation (Lopez-Lastra et al. 2005).
a) Leaky scanning
It has been shown that the nucleotide context in the 
vicinity of the start codon is important for its 
interaction with the ribosome. If the context is not 
optimal, some ribosomes do not recognize the 5’end 
proximal AUG codon as starting, skip it, and begin 
translation at the next AUG by mechanisms known 
as “leaky scanning” (Kochetov, 2006; Kozak, 
2002). This leaky scanning mechanism (Fig. 1, C2) 
produces protein isoforms with alternative amino 
initiation sites. Hence, the genes may produce sev-
eral versions of the encoded proteins, and the 
shorter versions, initiated from a downstream 
in-frame start codons, lack the N-terminal amino 
acids of the full-length isoform version (N-terminal 
truncated version) (Touriol et al. 2003).
Besides additional AUG codons located down-
stream to the main start codon, many mRNAs 
contain upstream located AUG (uAUG) which also 
may be chosen by translational mechanisms for 
synthesis of new isofunctional protein variants. 
Kochetov et al. (Kochetov et al. 2005) had ana-
lyzed more than 12000 of human mRNAs bearing 
uAUGs and found that 3% of mRNAs cantained 
uAUGs in the same reading frame as the coding 
sequences without stop codons in between. It 
means that such mRNAs can code for additional 
protein variants extended at the N ends. A com-
parison of their predicted subcellular locations 
showed that 31% of such N-extended proteins had 
a different location, and in 19% of the cases they 
had secretion signals absent from the annotated 
variants (Kochetov et al. 2005).
As the sequences that determine cell compart-
ment targeting are located usually at the N-terminal 
region of a protein, the selection of alternative 
translation initiation codons may be used by cell 
to control cellular localization of the isoforms (Cai 
et al. 2006; Gandre et al. 2003; Packham et al. 
1997). Cai et al. (Cai et al. 2006) showed that 
85.7% of alternative translation events generated 
biological diversity, attributed to different subcel-
lular localizations and distinct domain contents in 
alternative isoforms. Several examples presented 
below may illustrate how the leaky scanning 
mechanism is used by a cell for increasing diversity 
of protein isoforms produced by a single gene.
The Arabidopsis DNA ligase 1 gene (AtLIG1) 
is indispensable for cell viability. AtLIG1 
expresses one major and two minor mRNA tran-
scripts differing only in the length of the 5’ 
untranslated leader sequences preceding a com-
mon open reading frame (ORF) (Sunderland et al. 
2006). Control of AtLIG1 isoform production and 
intracellular targeting depends upon mechanisms 109
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controlling the choice of translation initiation site 
within the AtLIG1 ORF. Translation of AtLIG1 
mRNA transcripts from the ﬁ  rst in-frame start 
codon produces an AtLIG1 isoform that is targeted 
exclusively to the mitochondria. Translation 
initiation from the second in-frame start codon 
produces an AtLIG1 isoform targeted only to the 
nucleus. The length of the 5’-UTR and more sig-
niﬁ  cantly the nucleotide context around alternative 
start codons in the AtLIG1 transcripts affect trans-
lation initiation to ensure a balanced synthesis of 
both nuclear and mitochondrial AtLIG1 isoforms 
via a context-dependent leaky ribosome scanning 
mechanism (Sunderland et al. 2006). Instead of 
having distinct genes to code the different 
compartment-speciﬁ  c isoforms of DNA ligase 
proteins, eukaryotic species from yeast to humans 
appear utilize an evolutionarily conserved mech-
anism that relies upon choice of in-frame transla-
tion initiation start codons within the ORF of a 
ligase mRNA transcript to regulate the synthesis 
of the appropriate DNA ligase isoform destined 
for the nucleus or mitochondria. As the control of 
subcellular localization of proteins and their inter-
action with speciﬁ  c protein partners in vivo are 
crucial for cell physiology, the importance of the 
mechanisms controlling production of different 
forms of protein and their intracellular topology 
is difficult to overestimate (Sunderland et al. 
2006).
Ion channels are composed of membrane-
spanning proteins that allow ions to permeate at 
high rates. Voltage-gate K+ (Kv) channels are 
indispensable for the electrical excitability of nerve 
and muscle ﬁ  bers (Finol-Urdaneta et al. 2006). 
The N-terminal region of the Kv channels plays 
important regulatory roles, including inactivation 
kinetics, subunits recognition and redox modula-
tion of the currents ﬂ  owing through those channels. 
Thus, the differenes among N-terminal regions of 
Kv channels can result in important functional 
differences between molecular forms of Kv chan-
nels. The Kv 1.7 channels from mouse heart 
muscle are encoded by Kcna7 gene. Its mRNA 
transcript has two putative translation initiation 
start sites that generate two channel isoforms, 
mKv1.7L (489 aa) and mKv1.7S (457 aa), with 
different electrophysiological characteristics. The 
presence of both of these isoforms is very impor-
tant for normal functioning myocard as absence of 
one of them leads to different types of heart pathol-
ogy (Finol-Urdaneta et al. 2006).
Insulin-degrading enzyme (IDE) is expressed 
in both insulin-sensitive and insulin-insensitive 
tissues. Within the cell, IDE is targeted predomi-
nantly to cytoplasm, however, in some cells it 
presents also in several subcellular compartments. 
The mechanisms responsible for the targeting of 
IDE to different cell compartments are not well 
understood. Studing this issue, Leissring et al. 
(Leissring et al. 2004) showed that alternative 
translation beginning at an in-frame initiation 
codon located upstream of the canonical start site 
generates earlier nonrecognized isoform of insulin-
degrading enzyme that in contrast to cytoplasm 
locating isoform is targeted to mitochondria. This 
example shows that N-terminal extension achieved 
by usage of alterantive initiation codon can produce 
new protein isoform possessing new function.
These and many other examples (Porras et al. 
2006; Sass et al. 2001) demonstrate the power of 
leaky scanning mechanisms in generating multiple 
functionally different protein isoforms from single 
mRNA transcript.
b) Ribosome-shunting
The next translation mechanism that also makes 
impact in diversity of protein product coding for 
by a single gene is ribosome shunting. The scan-
ning model postulates that when a scanning 40S 
ribosomal subunit encounters a hairpin loop in the 
5’ UTR, it does not skip over the loop but unwinds 
it (Kozak, 1980; Lopez-Lastra et al. 2005). Nev-
ertheless, there are some cases when a scanning 
40S ribosomal subunit encounters the structures 
present in the 5’UTR and skips or shunts over a 
large segment, bypassing intervening segments 
including AUG codons and strong secondary struc-
tures that normally would block the scanning 
process (Fig. 1, C3). The selective translation ini-
tiation in adenovirus-infected cells under heat 
shock is an example of ribosome jumping mecha-
nism (Yueh and Schneider, 1996).
c) Termination-initiation
The third non-classical cap-dependent initiation 
mechanism, as it has already mentioned above, is 
termination-initiation. In the reinitiation mecha-
nism, a second ORF located in the same mRNAs 
can be translated without the 40S ribosome subunit 
becoming disengaged from the mRNA after reach-
ing the ﬁ  rst ORF stop codon (Fig. 1, C4). Strictly 
speaking this mechanism is more related to the 110
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elongation stage than to initiation one although the 
continuation of translation needs the reinitiation 
step at a downstream AUG triplet.
The exploration of the termination reinitiation 
mechanism for regulation of protein translation is 
observed in different cells and viruses. For exam-
ple, stress-induced eIF2α phosphorylation 
increases translation of ATF4, an activator of the 
integrated stress response (ISR) program, by 
reinitiation mechanism (Lu et al. 2004). The ATF4 
mRNA has two conserved upstream ORF (uORF), 
uORF1 and uORF2. Scanning ribosomes initiate 
translation at both uORFs. After translation of 
the uORF, the scanning ribosome efﬁ  ciently reiniti-
ate translation at downstream AUGs. In unstressed 
cells, low levels of eIF2α phosphorylation favor 
early capacitation of such reinitiating ribosomes 
directing them to the inhibitory uORF2, which 
precludes subsequent translation of ATF4 and 
repress ISR. In stressed cells high levels of eIF2α 
phosphorylation delays ribosome capacitation and 
favors reinitiation at ATF4 over the inhibitory 
uORF2 (Lu et al. 2004). Analogous mechanism 
operates in regulated translation of Gsn4 protein in 
yeast (Hinnebusch and Natarajan, 2002).
Translation of human hepatitis virus polymerase 
is another example demonstrating involvement of 
different translation mechanisms participating in 
expression of the polycistronic mRNA. The human 
hepatitis B virus (HBV) has a compact genome 
encoding four major overlapping coding regions: 
the core, polymerase, surface and X. The poly-
merase initiation codon is preceded by the partially 
overlapping core and four or more upstream ini-
tiation codons. Several mechanisms are used to 
enable the synthesis of the polymerase protein, 
including leaky scanning and ribosome reinitiation. 
Chen et al. (Chen et al. 2005a) showed that core 
upstream open reading frame (CO uORF), highly 
conserved in all HBV subtypes, played an inhibi-
tory role in downstream expression from the core 
initiation site, but also stimulated reinitiation at the 
polymerase start when in an optimal context. Thus, 
the CO uORF is a determinant in balancing the 
synthesis of the core and polymerase proteins.
2. Cap-independent IRES-determined 
initiation
The described examples demonstrate the possi-
bilities of cap-dependent initiation mechanisms to 
generate multiple protein isoforms possessing new 
functions. However, the possibilities of translation 
process to increase and diversify the potentials 
embedded in mRNA are not restricted only to cap-
dependent mechanisms as cap-independent trans-
lation mechanisms operate also in cells. 
Cap-independent translation (Fig. 1, C5) is medi-
ated by internal ribosome entry sites, IRES (Holcik 
et al. 2000). These are usually comprised of struc-
tured regions in the 5’ untranslated region and were 
initially identiﬁ  ed in viruses, but have since been 
reported in eukaryotic mRNAs and are believed to 
constitute a major form of regulation of protein 
synthesis in mammalian cells (Candeias et al. 
2006; Holcik et al. 2000). As a rule, there are no 
signiﬁ  cant structural similarities between indi-
vidual IRES. At present, IRESs are deﬁ  ned solely 
by functional criteria and cannot yet be predicted 
by the presence of characteristic RNA sequences 
or structural motifs (Lopez-Lastra et al. 2005). 
Examination of the available RNA structure predic-
tion software and RNA motif searching programs 
indicates that while these programs are useful tools 
to ﬁ  ne tune the empirically determined RNA sec-
ondary structure, the accuracy of de novo second-
ary structure prediction of large RNA molecules 
and subsequent identiﬁ  cation of new IRES ele-
ments by computational approaches, is still not 
possible (Baird et al. 2006).
a) Mix (or alternative) initiation
It is important that, although capped, some cellular 
mRNAs—including those encoding translation 
initiation factors, transcription factors, oncogenes, 
growth factors, homeotic gene products and sur-
vival proteins-contain also IRES elements in their 
5’UTR sequences that may allow them to be trans-
lated under conditions when cap-dependent syn-
thesis of proteins is impaired (Lopez-Lastra et al. 
2005). Moreover, in some cases mRNA molecule 
contains both cap-dependent start codon and IRES 
element and upon different cell conditions may 
direct synthesis of different isoforms of a single 
protein by using cap-dependent or IRES-mediated 
translation mechanisms (Fig. 1, C6). For instance, 
expression of two p53 isoforms, full length (FLp53) 
and N-terminal truncated (p53/47), is controlled 
by alternative cap-dependent and IRES-mediated 
mechanisms of initiation govern the translation of 
the p53 mRNA (Candeias et al. 2006). In contrast 
to FLp53, the p53/47 isoform does not harbour the 
most of N-terminal p53 transactivating domain 111
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(aa 1–40) nor the Mdm2-binding site (aa 17–23) 
demonstrating different functional parameters. The 
p53/47 may form complexes with FLp53 thus 
changing its stability and ability to induce activa-
tion of other p53-dependent genes. Changes in 
synthesis of FLp53 or p53/47 are regulated through 
distinct cell stress-induced pathways acting through 
separate regions of the p53 mRNA. The functional 
differences of two isoforms are manifested also in 
that that some cytotoxic agents require the presence 
of FLp53 to induce apoptosis, whereas for others 
p53/47 is sufﬁ  cient. This indicates that by harbour-
ing alternative translation initiation sites, the p53 
mRNA gives rise to different levels of the p53 
isoforms which help to orchestrate the cell bio-
logical outcome of p53 activation in response to 
different types of cell stress (Candeias et al. 
2006).
Another example showing the role of alternative 
translation initiation in synthesis of protein iso-
forms possessing different functions is vascular 
endothelial growth factor (VEGF). The unusually 
long (1038 nucleotides) and structured 5’ untrans-
lated region (UTR) of VEGF mRNA contains two 
independent IRES (IRES A and IRES B). In the 
human sequence, four potential CUG translation 
initiation codons are located in between these IRES 
and are in frame with the classical AUG start 
codon. The VEGF IRES A located within 300 
nucleotides upstream from the AUG codon directs 
a cap-independent translation initiation, which has 
been shown to allow VEGF synthesis in hypoxic 
conditions (Huez et al. 1998; Sass et al. 2001; Stein 
et al. 1998). It has been shown that IRES B located 
in the ﬁ  rst half of the 5’UTR between nucleotides 
379 and 483 controls the translation initiation of 
new VEGF isoform (L-VEGF) which is N-terminal 
extended by 206 amino acids in comparison to the 
classical AUG-initiated form. Translational initia-
tion of this isoform occurs at the ﬁ  rst of CUG 
codons. Different functions of two VEGF isoforms 
can be evidenced by different targeting of AUG- 
and CUD-initiated isoforms: while the classical 
AUG-initiated VEGF isoform is a secreted protien, 
the CUG-initiated L-VEGF isoform demonstrates 
intracellular targeting. Besides that the L-VEGF 
undergoes post-translational partial cleavage into 
two fragments, namely a 206-a.a. N-terminal frag-
ment that after cleavage remains in cell and a 
C-terminal fragment that is equeal to the AUG-
initiated isoform by size and by ability to be 
secreted out of the cell (Huez et al. 2001).
B. Elongation stage
Thus, at the initiation stage of translation process 
the translation apparatus has numerous possibilities 
for material (molecular) realization of the informa-
tion potentials consealed in mRNA. At the elonga-
tion stage other mechanisms may also make their 
impact in structural and functional diversity of 
synthesized protein isoforms. In contrast to the 
initiation and termination stages of translation, the 
machinery used during the course of translational 
elongation has been highly conserved and less 
variable across the three kingdom of life (Kapp 
and Lorsch, 2004). As noted by Namy et al. (Namy 
et al. 2004), the main mechanisms by which trans-
lation machinery may uncover the hidden genetic 
information at the elongation stage are the frame-
shifting (Fig. 1, D2) and to a less degree—hopping 
(Fig. 1, D3).
1. Frameshifting
Prediction the protein(s) encoded by a given DNA 
is difﬁ  cult because of the lack of knowledge of the 
signals embedded in the genome that are involved 
in the translation of the genetic information. It has 
been shown that in many genes the standart rules 
of decoding postulated by the dogma of the uni-
versal genetic code are subverted by “recoding” 
signals found in DNA that promote alternative 
decoding events like programmed ribosomal 
frameshifting, hopping, or termination codon reas-
signment (Atkins et al. 2001; Gesteland and Atkins, 
1996; Gesteland et al. 1992).
As noted by Namy et al. (Namy et al. 2004) 
“natural frameshift errors occur very reraly, but 
programmed ribosomal frameshifting signals 
increase the probability of tRNA slippage enor-
mously, occasionally to such an extent that up to 
50% of ribosomes change frame”. Analysis of the 
frameshifting mechanisms is beyond this review 
scope. They were critically studied and described 
in several excellent publications (Atkins et al. 
2001; Brierley and Pennell, 2001; Plant et al. 2003; 
Stahl et al. 2001). In principle, frameshifting is 
triggered by two elements—a slippery and stimu-
lator sequences. A slippery sequence is the mRNA 
region where tRNA movement or misalignment is 
favored while a stimulator is the mRNA sequence 
that ehhances framshifting by induction of a ribo-
somal pause (Namy et al. 2004).
Different kinds of frameshifting were described 
both in prokaryotes and eukaryotes. For example, 112
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programmed frameshifting was observed in 
translation of the prokaryotic DNA polymerase III, 
α-fucosidase and release factor 2 (RF2) as well as 
eukaryotic proteins such as antizyme-1 (AZ1), 
IL-10, ABP140 etc [cited by (Namy et al. 2004)]. 
The biological expediency and functions of such 
frameshifting are different in each case however it 
is always warranted. For instance, in the case of 
RF2 the recoding frameshift represents an auto-
regulatory mechanism controling the abundance 
of RF2. At high RF2 levels, the competition 
between termination and frameshifting is shifted 
in favor of termination, leading to a decrease of 
the RF2 concentration in the cell. When level of 
RF2 begins to decrease, frameshifting begins to 
predominate, raising the level of RF2 (Adamski 
et al. 1993).
The antizyme-1 (AZ1) is another well studied 
example of a protein which full length expression 
is regulated by programmed frameshifting. AZ1 is 
a protein that negatively regulates polyamine syn-
thesis by inhibiting the key synthetic enzyme 
ornithine decarboxylase and targeting it for degra-
dation by the 26S proteasome (Heller et al. 1976; 
Murakami et al. 1992). Like RF2, the AZ1 full 
length protein expression depends on frameshifting 
which in its turn is linked to a feedback mechanism 
which regulates polyamine levels in mammalian 
cells. For AZ1, when cellular polyamine levels are 
low, the polypeptide corresponding to amino acid 
residues 1–68 is produced and translation is termi-
nated at the following UGA stop codon (Matsufuji 
et al. 1995). When cellular polyamine levels are 
high, +1 frameshifting occurs after the 68th codon 
resulting in the full-length antizyme protein con-
taining 227 amino acid residues (1–227 a.a.) 
(Ichiba et al. 1994). Frameshifting is employed in 
the expression of all known antizymes in different 
species and many other proteins. The concervation 
of this mechanism throughout evolution highlights 
a crucial role for frameshifting in the regulation of 
gene expression.
It should be pointed out that frameshifting 
determines multifunctionality of AZ1 only par-
tially. Differential usage of alternative initiation 
sites also makes its impact in this phenomenone. 
AZ1 mRNA contains two initiation AUG codons 
separated by 32 codons. Both AUG triplets are 
utilized as translation start sites (Matsufuji et al. 
1995; Rom and Kahana, 1994). It has been shown 
that N-terminal region of AZ1 contains nuclear 
export and mitochondrion targeting signals 
(Gandre et al. 2003; Gritli-Linde et al. 2001; Murai 
et al. 2003). Depending on either AUG codon is 
used for translation, the resulting AZ1 isoform is 
targeted to nucleus, mitochondria or cytoplasm 
(Murai et al. 2003). The multifunctionality of 
antizyme was evidenced not only by targeting of 
its isoforms to different cell compartments and 
serving as ornithine decarboxylase inhibitor but 
also by recent ﬁ  nding that AZ1 functions as posi-
tive transcriptional regulator of the atoDAEB 
operon genes in E.coli (Filippou et al. 2007).
We have described here only two proteins which 
synthesis are directed by frameshifting. Many other 
examples in which this mechanism is used for 
development of protein diversity may be found in 
very informative review written by Namy et al. 
(Namy et al. 2004).
2. Hopping (translational bypassing)
An unusual frameshift event that also diversiﬁ  es 
the protein structures and functions is “hopping” 
where the transition from frame 0 to another frame 
occurs by translational bypassing of an extended 
region of the mRNA sequence rather than by slip-
page past a single nucleotide, as has been described 
for most examples of frameshifting. When genetic 
code has been discovered, its translation seemed 
to be rigid. However, later on the reading of the 
genetic text (code) has been found to be quite ﬂ  ex-
ible, and several alternatives in its expression have 
been described (Groisman and Engelberg-Kulka, 
1995).
Translational bypassing joins the information 
found within two disperate open reading frames 
into a single polypeptide chain. The underlying 
mechanism centers on the decoding properties of 
peptidyl-transfer RNA (tRNA) and involves three 
stages: take-off, in which the peptidyl-tRNA/
mRNA complex in the P-site of the ribosome dis-
sociates; scanning, at which the peptidyl-tRNA 
probes the mRNA sliding through the decoding 
center; and landing, in which the peptidyl-tRNA 
re-pairs with a codon with which it can form a 
stable interaction (Fig. 1, D3) (Herr et al. 2000a). 
The best characterized examples of this phenom-
enon are T4 gene 60 and plaA gene (the Prevotella 
loescheii adhesion gene). In T4 gene 60, a complex 
signals stimulates bypassing of 50 nucleotides 
between the two open reading frames (Herr et al. 
2000b). In plaA, the translation of its mRNA 
requires bypassing of 29-nt of coding gap (Manch-
Citron et al. 1999).113
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Herr et al. (Herr et al. 2000a) noted that 
although few examples of genes are known that 
rely on translational bypassing to couple ORFs, 
ribosomes appear to have innate capacity for 
bypassing. This suggests that the strategy of trans-
lational bypassing may be more common than 
presently appreciated.
C. Termination stage
Termination of protein synthesis involves the 
decoding of a stop signal through an interaction 
between ribosome, mRNA and release factors (RF) 
that facilitates the hydrolytic release of the nascent 
polypeptide chain from the peptidyl-transferase 
center of the ribosome (Cridge et al. 2006). Stop 
codons are used to signal the ribosome to terminate 
the decoding of an mRNA template. Open reading 
frames within an mRNA are terminated by an in-
frame any one of three stop or nonsense codons 
(UAA, UAG or UGA) which are recognized during 
translation by the binding of RFs to the ribosomal 
A site (von der Haar and Tuite, 2007; Williams 
et al. 2004).
1. Stop codon readthrough
Translation termination is normaly a highly efﬁ  -
cient process. It has been shown that stop codons 
are normally suppressed at a frequency of only 
0.001%–0.1% (Loftﬁ  eld and Vanderjagt, 1972; 
Stansﬁ  eld et al. 1998). Two competing events, 
termination and stop codon readthrough (or non-
sense suppression), can occur when stop codon 
reaches the A-site of a translating ribosome. Trans-
lation termination results in hydrolysis of the ﬁ  nal 
peptidyl-tRNA bond and release of the completed 
nescent polypeptide. Alternatively, readthrough, 
in which the stop codon is erroneously decoded by 
a suppressor or near-cognate t-RNA, results in 
translation past the stop codon and production of 
a protein with a C-terminal extention (Fig. 1, E). 
The relative frequency of termination versus 
readthrough is determined by parameters such as 
the upstream and downstream stop codon nucleo-
tide contexts, the activities of termination polypep-
tide-chain release factors and the abundance of 
suppressor near-cognate t-RNAs. All these param-
eters modulate the balance of termination to 
readthrough reactions in a cell-type-speciﬁ  c man-
ner (Bonetti et al. 1995; Fearon et al. 1994; Janzen 
and Geballe, 2004; Keeling et al. 2004; Namy et al. 
2002). Willams et al. (Williams et al. 2004) 
underline that “the potential for even short 
C-terminal extention (peptide tags) to alter the 
cellular localization or activity of a protein is great. 
Addition of even a single amino acid could com-
plete a partial targeting signal already present at 
the C-terminus of a protein. All protein extensions 
altering targeting could potentially act as geneti-
cally dominant, gain of function events. Thus, 
despite the generally low efﬁ  ciency of stop codon 
readthrough events, such events may well have 
phenotypic consequence for the cell”.
There are an increasing number of examples of 
stop codon readthrough, both in viral and cellular 
systems, and in many cases this readthrough has 
physiological consequences for the cell. It is 
become obviously that different cells and organ-
isms not only accommodate stop codon as a main-
stream termination signal, but also used it to 
provide these cells and organisms ﬂ  exibility to 
respond physiologically to various changeable 
environments (Namy et al. 2002; Steneberg and 
Samakovlis, 2001; Tate et al. 1999; Yoshinaka et al. 
1985). The alternative non-canonical usage of stop 
codons allows production of several polypeptides 
from one open reading frame thus increasing struc-
tural and functional diversity of one gene products 
(Doronina and Brown, 2006). The classical illustra-
tion to this statement is selenoproteins.
More that 15 animal selenoproteins have been 
described. Many selenoproteins, such as glutathi-
one peroxidase (Sukenaga et al. 1987), type I 
iodothyronine 5’-deiodinase (5’DI) (Berry et al. 
1991b) and thioredoxin reductase (Gasdaska et al. 
1995) are enzymes which catalyze oxido-reduction 
reaction. All selenoproteins contain selenocysteine 
(Sec). Selenocysteine incorporation is speciﬁ  ed 
by a UGA codon in the open reading frame of the 
mRNA that is accompanied by a “selenocysteine 
insertion sequence” element (SECIS) in the 
3’ UTR (Berry et al. 1991a; Goto et al. 2001). 
However, in deﬁ  nite conditions this UGA codon 
may also serve as a stop codon. The competition 
between UGA as a stop signal and as the code for 
the Sec has been observed during expression of 
the deiodinase gene. Both the termination product 
(14 kD) and the complete iodinase protein (28 kD) 
could be detected within cells (McCaughan et al. 
1995). The relative amounts of these products 
could vary with cell type and expression system, 
reﬂ  ecting a competition between the two UGA 
decoding mechanisms (Steneberg and Samakovlis, 
2001).114
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The selenoprotein P represents even more strong 
illustration of competition between UGA as a stop 
codon and UGA as a triplet that specifies 
Sec-incorporations. Selenoprotein P is an extracel-
lular glycoprotein that has been suggested to serve 
in oxidant defense (Burk et al. 1995). Its mRNA 
contains 10 UGA codons in an open reading frame 
terminated by a UAA, implying 10 selenocysteines 
in the primary structure of the protein (Hill et al. 
1991). Full-length selenoprotein P and three 
smaller isoforms that have identical N termini but 
different afﬁ  nity to heparin-Sepharose have been 
detected in rat plasma (Chittum et al. 1996). By 
mass spectrometric peptide analysis it was evi-
denced that the full-length isoform contains pre-
dicted amino acid residues, including its C 
terminus and all 10 selenocysteines. The shortened 
isoforms terminated where the second, third 
and seventh selenocysteines residues were pre-
dicted to be (Ma et al. 2002). This suggests that all 
isoforms arise from the same mRNA and that the 
UGAs that specify the second, third and sevenths 
selenocysteines in full-length selenoprotein P can 
alternatively serve to terminate translation, produc-
ing the shorter isoforms. As Ma et al. (Ma et al. 
2002) pointed out, “it remains a theoretical 
possibility that the shorter isoforms are produced 
from the full-length protein by proteolysis”. How-
ever, the protease that could cleave the protein at 
speciﬁ  c selenocysteine residue is unknown, and 
this excludes the possibility of proteolytical cleav-
age of the full-length isoform at the specific 
Sec-sites.
The Drosophila kelch gene is another example 
showing that translational control of gene expres-
sion may be realized through stop codon suppres-
sion and readthrough. It has been demonstrated by 
Robinson and Cooley (Robinson and Cooley, 1997) 
that the kelch gene produces a single transcript with 
a UGA stop codon separating two open reading 
frames (ORF1 and ORF2). From the transcript, 
76 kDa ORF1 and 160 kDa full-length (ORF1+ 
ORF2) proteins are expressed. The expression of 
these two proteins is regulated in tissue-speciﬁ  c 
manner causing the ratio of two isoforms to vary 
in different tisuues (Robinson and Cooley, 1997).
The important role of “leaky” stop codon and 
readthrough mechanism for cell physiology can be 
illustrated also by the yeast PDE2 gene which 
encodes the high afﬁ  nity cAMP phophodiesterase. 
By synthesis the cAMP phosphodiesterase this 
gene may regulate the intracellular concentration 
of cAMP and thus protect the cell from extracel-
lular cAMP (Wilson et al. 1993; Wilson and 
Tatchell, 1988). When the translation of the PDE2 
mRNA is terminated at leaky stop codon, the pde2 
protein (active phosphodiesterase) is synthesized 
leading to low level of intracellular cAMP and 
increased stress sensitivity. On the contrary, when 
stop codon readthrough mechanism is switched 
on, the C-terminal extension of 21 amino acids 
occurs leading to pde2 protein destabilization 
which in its turn results in high level of cAMP in 
the cell and resistance to stress environment (Namy 
et al. 2002; von der Haar and Tuite, 2007). The 
PDE2 is thus an example of an individual gene 
product in Saccharomyces cerevisiae where alter-
ations in stop-codon readthrough are directly 
linked to phenotypic variations that have crucial 
consequence for cell physiology.
When physiological roles of canonical termina-
tion signals, leaky stop-codons and readthrough 
mechanisms are discussed, the principle difference 
between normal function of termination stop codon 
and abnormal role of premature stop codon(s) 
which may appear in the mRNA as result of muta-
tions or alternative splicing to cryptic splice sites 
should be underlined (Frischmeyer and Dietz, 
1999; Lewis et al. 2003). The nucleotide context 
surrounding the classical stop codon is genetically 
determined and promotes translational termination 
of the synthesized natural protein. The upstream 
and downstream contexts of leaky stop signal are 
also genetically determined for promotion of the 
readthrough activity which results in appearance 
of new protein isoform that is necessary for fulﬁ  ll-
ment of speciﬁ  c physiological function. Thus, the 
expression of terminated or extended proteins in 
these cases represents realization of speciﬁ  c steps 
in the normal cell program. The random appearance 
of the premature termination codon (PTC), or 
nonsense codon, in ORF of mRNA is not correlated 
with the inherited surrounding nucleotide context 
and therefore cannot be regulated by physiological 
translation mechanisms (Lewis et al. 2003).
Nonsense codon-bearing transcripts typically 
encode C-terminally truncated proteins which 
could possess dominant-negative or deleterious 
gain-of-function effects. Usually, PTCs trigger the 
rapid degradation of mRNA by nonsense-mediated 
mRNA decay (NMD) mechanism that detects and 
degrades transcripts harboring nonsense codons 
(Frischmeyer and Dietz, 1999; Wilkinson, 2005). 
This downregulatory response is an important 115
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quality-control mechanism. Its function is safe-
guarding cells from abnormal mRNA function 
(Behm-Ansmant et al. 2007; Isken and Maquat, 
2007). Surprisingly, recent studies strongly evi-
denced that components of NMD machinery 
(proteins UPF1, UPF2, UPF3, RNP21, Y14 and 
MAGOH) also promote translation of normal 
mRNAs in mammalian cells (Nott et al. 2004; 
Wiegand et al. 2003; Wilkinson, 2005). It has been 
shown that the function of NMD proteins depends 
on their location. If located within an ORF, NMD 
factors stimulate translation and control high-
ﬁ  delity translation termination. If located down-
stream of an ORF, they elecit RNA decay 
(Lykke-Andersen et al. 2001; Maderazo et al. 
2000; Wang et al. 2001; Wiegand et al. 2003; 
Wilkinson, 2005). Thus, NMD proteins also dem-
onstrate multifunctionality participating in two 
oposite processes. On the one hand, by takeing part 
in NMD, they degrade mRNA and decrease the 
level of protein synthesis. On the other hand, by 
binding to mRNA within ORF, they stimulate 
protein syntesis and even correct naturally occur-
ring mistakes (Wilkinson, 2005).
The described examples not only document the 
existence of several evolutionary conserved 
mechanisms of translation destined for production 
of multiple and functionally different isoforms of 
one gene product but also show that proteins 
involved in these mechanisms are multifunctional 
molecules that simultaneously may participate in 
opposite processes leading to decreasment and to 
increasment of protein synthesis. These mecha-
nisms make a substantial impact in transformation 
of compact genetic information in diverse protein 
moiety.
Post-translational modiﬁ  cations
Although the amino acid structure of a protein is 
deﬁ  ned by the gene and mRNA encoding the 
protein, its ﬁ  nal functional structure is achieved 
by numerous post-transclational modiﬁ  cations. 
The majority of all proteins undergo co- and/or 
post-translational modiﬁ  cations (Rehfeld and 
Goetze, 2003). Knowledge of these modiﬁ  cations 
is extremely important, since they may alter 
physical and chemical properties, conformation 
distribution, folding, stability, activity, and, con-
sequently, function of the proteins. The protein 
precursor may undergo a wide variety of proteo-
lytic cleavages, N- and C-terminal trimmings and 
amino acid derivatization in cells that express 
the protein. Occasionally, the same precursor is 
differently processed in different cell types 
(Rehfeld and Goetze, 2003). According to 
Rehfeld and Goetze (Rehfeld and Goetze, 2003) 
all post-translational modifications may be 
divided in three groups [Table 1 cit. from 
(Rehfeld and Goetze, 2003)].
Although this table contains many types of post-
translational modiﬁ  cation, it can not be considered 
as a complete list of possible modiﬁ  cation. For 
example, it does not contain such modiﬁ  cation as 
palmitoylation, ubiquitylation, methylation, pro-
tein folding and protein splicing which appear to 
be a powerful mechanism of protein diversity 
(Draper et al. 2007; Hanada et al. 2004; Mostaqul 
Huq et al. 2008; Nagradova, 2004; Perler, 2005; 
Schartner et al. 2007). The limit of the review 
volume does not allow discussion of all the pos-
sible post-translational modifications depicted 
in Fig. 1, F. Therefore, we will concentrate just 
on some of them—phosphorylation, glycosylation, 
palmitoylation, protein folding and protein 
splicing.
1. Protein phosphorylation
Protein phosphorylation is one of the most wide-
spread type of post-translational modiﬁ  cation of 
protein that allows the cell to control various cel-
lular processes, including signal transduction, 
transcriptional and translational mechanisms, 
Table 1. Post-translational modiﬁ  cations.
Endoproteolytic cleavages:
1. Dibasic  sites
2. Monobasic  sites
3.  Post(poly) Clu/Asp sites
4. Post  Phe-sites
5.  Tri and tetrabasic sites
Exoproteolytic trimmings:
1. Carboxyamidation
2. Glutaminyl  cyclation
3.  N-terminal dipeptidyl cleavage
Amino acid derivatizations:
1. Acylations
2. Disulﬁ  de bridgings
3. Gamma  carboxylation
4. Glycosylations
5. Isomerisatios
6. Phosphorylations
7. Sulfations116
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metabolism, growth, division, differentiation, 
motility, organelle trafﬁ  cking, membrane transport, 
immunity, learning and memory (Manning et al. 
2002a; Manning et al. 2002b). In eukaryotic cells, 
most phosphorylation occurs on Ser, Thr and Tyr 
residues (Ubersax and Ferrell, 2007). The phos-
phorylation state of phosphoproteins is controlled 
by the activity of protein kinases and phosphatases 
(Urner and Sakkas, 2003). According to calculation 
performed by Ubersax and Ferrell (Ubersax and 
Ferrell, 2007), a typical protein kinase must rec-
ognize between one and a few hundred bona ﬁ  de 
phosphorylation sites in a background of about 
700,000 potentially phosphorylatable residues in 
typical eukaryotic cell. Multiple mechanisms have 
evolved that contribute to this exquisite speciﬁ  city, 
including the structure of the catalytic site, local 
and distant interactions between the kinase and 
substrate, the formation of complexes with scaf-
folding and adaptor proteins that spatially regulate 
the kinase etc (Ubersax and Ferrell, 2007).
Although different kinases demonstrate their 
individual speciﬁ  cities and peculiarities in phos-
phorylation processes, the main results of this 
post-translational modiﬁ  cation are structural and 
functional changes of the substrate protein. Several 
examples can illustrate this statement.
Many nuclear receptors have been found to be 
modified by phosphorylation (Rochette-Egly, 
2003). Testicular receptor 4 (TR4) is an orphan 
member of the nuclear receptor superfamily. In the 
absence of speciﬁ  c ligands the activity of TR4 can 
be modulated by mitogen-activated protein kinase 
(MAPK)-mediated phosphorylation of its AF-1 
domain (activation function 1). MAPK-mediated 
phosphorylation of the AF-1 domain renders TR4 
a repressor while dephosphorylation of the AF-1 
domain makes TR4 an activator (Huq et al. 2006). 
Reversible protein phosphorylation, like bidirec-
tional regulation of TR4, is known to control a 
wide range of biological activities (Chen et al. 
2005b; Collins et al. 2004; Kim et al. 2003; 
Koritschoner et al. 2001; Shyr et al. 2002; Tanabe 
et al. 2002).
Another example also may show the power of 
post-translational phosphorylation in determing 
the protein function. Glucose-mediated phos-
phorylation converts the transcription factor Rgt1 
from a repressor to an activator (Mosley et al. 
2003). In the yeast Saccharomyces cerevisiae, 
glucose induces the expression of the hexose trans-
ported /HXT/ genes by modulation the activity of 
transcription factor Rgt1 that functions as a 
repressor when glucose is absent. However, in the 
presence of high concentration of glucose, Rgt1 is 
converted from a repressor to an activator by glu-
cose-mediated phosphorylation. Rgt1 activator is 
required for maximal induction of HXT1 gene 
expression (Mosley et al. 2003).
Several transcription factors, as well as other 
proteins, have been shown to change their subcel-
lular localization in response to external stimuli 
(De Vit et al. 1997; Komeili and O’Shea, 1999). 
Yeast protein Mig1 is phosphorylated by the Snf1 
kinase in the absence of glucose and is trapped in 
the cytoplasm. High concentrations of glucose 
cause dephosphorylation of Mig1 and translocation 
into the nucleus (Komeili and O’Shea, 1999; 
Treitel et al. 1998). The subcellular localization of 
the other yeast protein, Pho4, is regulated in 
response to another agent, phosphate. At high 
concentrations of phosphate, Pho4 is phosphory-
lated and exported into cytoplasm, whereas starva-
tion for phosphate causes dephosphorylation of 
Pho4 and translocation into the nucleus (Komeili 
and O’Shea, 1999).
These examples clearly demonstrate that deﬁ  -
nite functional potentials encoded in the primary 
protein structure by speciﬁ  c topology of Ser, Thr 
and Tyr residues may be uncovered and realized 
by speciﬁ  c phosphorylation events.
2. Glycosylation
Glycosylation is another widely observed post-
translational modiﬁ  cation of proteins. Proteins can 
be glycosylated on certain amino acid side-chains, 
and these modiﬁ  cations are designated as N- and 
O-glycosylation (Medzihradszky, 2002). 
N-glycosylated species are modiﬁ  ed at Asn resi-
dues. O-glycosylation occurs at Ser or Thr-residues. 
It should be noted that characterization of both 
types of glycosylation is complicated by the fact 
that in some cases the same amino acids within a 
population of protein molecules may be derivatized 
with an array of different carbohydrate structures 
while in other cases they may remain unmodiﬁ  ed. 
This site-speciﬁ  c heterogeneity may vary by spe-
cies, tissue and may be affected by physiological 
changes (Medzihradszky, 2002). Thus, the same 
protein may be glycosylated in one type of cells 
and unmodiﬁ  ed in another type of cell and the dif-
ference in glycosylation status will be reﬂ  ected by 
different functions of a given protein in different 117
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cells (Bloom et al. 1996; Hironaka et al. 1993). 
The analogous situation can be observed even in 
the same cells, however, at different physiological 
conditions (Nemansky et al. 1998).
The purpose of glycosylation, as any other post-
translational modiﬁ  cation, is to uncover functional 
activities hidden in the protein structure. By adding 
sugars to polypeptide molecule, glycosylation 
changes it structure in such a way that new 
function(s) may occur. For instance, Miranda et al. 
(Miranda et al. 2007) showed that neutralization 
properties of the HIV-speciﬁ  c antibody F240 were 
dramatically altered by glycosylation. This Ab, 
when produced in a hybridoma, is nonneutralizing. 
However, F240 IgG1 Ab expressed in CHO cells 
acquired a strong neutralization activity without a 
change in immunoreactivity. Sequencing of the 
F240 mRNA produced in the parental hybridoma 
and CHO cells revealed identical sequences, sug-
gesting that acquired neutralization resulted from 
cell-specific post-translational modifications. 
Among different types of post-translational modi-
ﬁ  cation which the Abs may undergo during their 
intracellular maturation process, N-linked glyco-
sylation is one of the best characterized. It is widely 
acknowledged that an Ab expressed in CHO cells 
is differentially glycosylated as compared with an 
Ab produced in other mammalian cells (Routier 
et al. 1997; Sheeley et al. 1997). Miranda et al. 
(Miranda et al. 2007) showed that the Ab produced 
by CHO cells is glycosylated to a greated extent 
than parental Ab produced by the hybridoma. It 
was found that the F240 Ab produced in CHO 
cell had signiﬁ  cantly more terminal glycans and 
core fucose when compared with the F240 Ab 
from hybridoma. Moreover, treatment with pep-
tide N-glycosidase F abrogated F240 neutraliza-
tion. This study showed that structural changes 
induced by additional N-glycosylation in the F240 
Ab determined functional changes in its neutral-
izing activity.
Two other examples show the effect of 
O-glycosylation on the conformation and biologi-
cal activities of two other proteins, calcitonin and 
prion protein. Using different O-glycosylated cal-
citonin derivatives, each with a single GalNAc 
residue attached to either Ser or Thr, Tagashira 
et al. (Tagashira et al. 2001) have demonstrated 
that calcitonin conformation and its hypocalcemic 
activity were strongly dependent on O-glycosila-
tion. Moreover, these authors evidenced that effect 
of glycosylation was clearly site-specific: 
glycosylation at Thr-6 affected both the structure 
and activity, at Ser-5 only activity and at Ser2 none, 
indicating that the site dependence was very strict. 
The drastic difference in the hypocalcemic activity 
observed in this study could be explained by the 
steric inhibition of the interaction with the receptor 
(Tagashira et al. 2001).
It has been known for a long time that the struc-
tural transition from PrP-c, the normal product of 
the prion gene, to PrP-sc, the pathological form of 
the protein, leads to the prion formation and to 
disease, however, the mechanism of this transition 
was obscured. Based on prion peptide studies, 
Chen et al. (Chen et al. 2002) provided evidence 
for linking of O-glycosylation to the structural 
transition of PrP-c to PrP-sc. They found that 
O-linked α-GalNAc at Ser-135 suppressed the 
development of the amyloid ﬁ  bril formation of the 
prion peptide at physiological salt concentration, 
whereas the peptide with the same sugar but at 
different location, at Ser-132, showed the opposite 
effect. Moreover, this effect was sugar speciﬁ  c: 
replacing α-GalNAc with β-GalNac did not yield 
the same effect (Chen et al. 2002).
As we have alredy noted, many types of post-
translational protein modifications have been 
described (Rehfeld and Goetze, 2003). They all are 
directed to modify structure of the parental poly-
peptide chain thus increasing number of protein’s 
functions. It is apriori obviously, that for achieve-
ing maximal functional variability and adaptivity 
to environment by post-translational modiﬁ  cation, 
the compact polypeptide structure must contain 
sites that might be sensitive to different type of 
modiﬁ  cation. Moreover, the same site could be 
sensitive to different modifying reactions, so the 
different modifying agents could compete for these 
sites (competitive modiﬁ  cation). The correctness 
of such suggestion was conﬁ  rmed by the discovery 
that phosphorylation and glycosylation may com-
pete for and modify the same amino acid residues 
in targeted proteins (Kelly et al. 1993).
The O-linked β-N-acetylglucosamine 
(O-GlcNAc) is a monosaccharide modiﬁ  cation 
abundant on serine and threonine residues of a 
multitude of nucleo-cytoplasmic proteins in virtu-
ally all higher eukaryotes, including plants and 
fungi (Comer and Hart, 2000; Hart, 1997; Hart 
et al. 2007; Torres and Hart, 1984; Wells and Hart, 
2003). The attachment and removal of O-GlcNAc 
by O-GlcNAc-transferase and O-GlcNAcase, 
respectively, is rapid reactions analogous to 118
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dynamics of O-phosphate adding or removing 
controlled by kinases and phosphatases (Dong and 
Hart, 1994; Haltiwanger et al. 1992; Haltiwanger 
et al. 1990; Krebs, 1993; Kreppel et al. 1997; 
Kreppel and Hart, 1999; Lubas et al. 1997). It has 
been shown that O-GlcNAc sites resemble phos-
phorylation sites, and in many cases the two 
modiﬁ  cations are mutually exclusive (Kelly et al. 
1993). Reversible phosphorylation and alternative 
glycosylation induce changes in secondary and 
tertiary structures and control the functional behav-
iour and modular interactions of proteins (Ahmad 
et al. 2007; Cheng and Hart, 2001; Pawson and 
Gish, 1992). For example, in case of estrogen 
receptor β (Cheng et al. 2000), SV-40 large T anti-
gen (Medina et al. 1998) and the c-Myc oncogen 
(Chou et al. 1995a; Chou et al. 1995b), O-GlcNAc 
and O-phosphate compete for the same hydroxyl 
moiety. Like phosphorylation, O-GlcNAcylation 
is responsive to the cell cycle, extracellular signals, 
glucose metabolism, cell growth and regulation of 
transcription and translation (Chou and Omary, 
1994; Datta et al. 1989; Du et al. 2000; Han et al. 
2000; Kearse and Hart, 1991; Roos et al. 1997; 
Roquemore et al. 1996).
The examples described above show once again 
that primary protein has many possibilities to be 
modiﬁ  ed. What type of modiﬁ  cation it will undergo 
depends on many factors such as cell type, cell 
cycle, extracellular and intracellular signals, pH 
gradient, local concentrations of speciﬁ  c modifying 
molecules etc. As a result, the protein will possess 
a speciﬁ  c function in an appropriate cell, at deﬁ  nite 
cell compartment and at the precise time.
3. Protein palmitoylation
The next type of protein modiﬁ  cation that we would 
like to discuss is S-palmitoylation. A major mecha-
nism by which cells regulate the subcellular localiza-
tion of proteins is post-translational lipidation 
(Draper et al. 2007). S-palmitoylation is one of lipid 
modiﬁ  cations that is reversible thioester linkage of 
palmitate, a 16 carbon saturated fatty acid, to cystein 
residues (S-palmitoylation) catalyzed by membrane-
bound palmitoyl-transferases (PATs). Palmitoylation 
increases the hydrofobicity of the modeﬁ  ed mole-
cules (Greaves and Chamberlain, 2007).
It is apriori obviously, that simultaneous display 
of the principles of structural compactness with 
maximal functional variability demands that sites 
on the polypeptide molecule that may undergo 
different types of modiﬁ  cation should be over-
lapped or even be the same, and different modify-
ing agents should compete for these sites of 
proteins by altering their conformation. The 
changes in structure of proteins promotes their 
localization to speciﬁ  c cellular compartments, 
contributes to their membrane association and 
control protein-protein interactions. They also 
regulate subcellular trafﬁ  cking of proteins between 
membrane organelles and within microdomains of 
the same membrane compartments and modulate 
their functions (Bijlmakers and Marsh, 2003; 
Casey and Seabra, 1996; Dunphy and Linder, 1998; 
el-Husseini Ael and Bredt, 2002; Milligan et al. 
1995; Nadolski and Linder, 2007; Resh, 1999; 
Silvius, 2002).
For many palmitoylated proteins, the half life 
of the palmitate moieties is signiﬁ  cantly shorter 
than that of the substrate proteins, indicating that 
the complex goes through cycles of depalmi-
toylation and repalmitoylation. The reversibility 
of palmitoylation suggests that it is a regulated 
modiﬁ  cation much like protein phosphorylation. 
Depalmitoylation and repalmitoylation could pro-
vide a mechanism to regulate such processes as 
binding cytosolic proteins to membranes, segregat-
ing proteins to microdomains and mediating 
protein-protein interaction. For proteins involved 
in signal transduction, these cycles could be 
induced by activation and by controlling access to 
speciﬁ  c substrates (Bijlmakers and Marsh, 2003; 
Casey and Seabra, 1996; Dunphy and Linder, 1998; 
el-Husseini Ael and Bredt, 2002; Milligan et al. 
1995; Nadolski and Linder, 2007; Resh, 1999; 
Silvius, 2002). Palmitate cycling on the scaffolding 
protein PSD-95 may illustrate this mechanism. 
Palmitoylation allows PSD-95 to cluster in the 
postsynaptic membrane. Blocking of PSD-95 pal-
mitoylation leads to a loss of AMPA receptors from 
these domains by the rapid endocytosis of AMPA 
receptors which requires depalmitoylation of 
PSD-95 (el-Husseini Ael and Bredt, 2002; Nadolski 
and Linder, 2007).
Several other examples can additionally illus-
trate the roles of palmitoylation in protein function-
ing. It has been shown that palmitoylation controles 
the regulator of G-protein signaling (RGS). Pal-
mitoylation of the Cys residue in the RGS box is 
essential for RGS16 GAP activity and their ability 
to regulate G-coupled signaling in mammalian 
cells. Enzymatic palmitoylation of RGS16 results 
in internal palmitoylation on residue Cys-98. 119
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Mutation of this residue to alanine reduces GAP 
activity of the 5-HT-1A/Gα fusion protein (Oster-
hout et al. 2003).
S-palmitoylation, as shown by study of Marino 
et al. (Marino et al. 2006), can modulate estrogen 
receptor α (ER α) localization and functions. In 
cells expressing wild-type of ERα, a major popu-
lation of estrogen receptor was membrane-associ-
ated whereas in cells expressing the ERα 
Cys447-Ala mutant no membrane-bound recep-
tor has been detected. Moreover, ERα Cys447-Ala 
mutation does not allow E2-induced proliferative 
signaling via ERK/MAPK and P13K/AKT path-
ways in human cancer cells (Acconcia et al. 2005). 
As a whole, S-palmitoylation allows the extra-
nuclear localization of ERα and promotion down-
stream of signaling for E2-mediated proliferation 
(Marino et al. 2006).
S-palmitoylation, like phosphorylation and 
glycosylation, is important post-translational 
modiﬁ  cation that provides proteins with many 
important functions and controls cell processes 
dependent on these functions. Thus, as other post-
translational modiﬁ  cations, palmitoylation fulﬁ  lls 
the main principle of protein structural/functional 
relationship: gaining maximal functional activities 
by introducing minimal but speciﬁ  c changings in 
the protein structure.
4. Protein folding
The protein architecture opens many ways for 
proteins to obtain multiple functions. Evolution 
gives many examples conﬁ  rming this statement. 
In some cases, evolution can merge proteins by 
chaning tertiary to quaternary structure. For 
instance, ﬁ  ve separate enzymes in the bacterium 
E.coli that catalyse successive steps in the pathway 
of biosynthesis of aromatic amino acids, corre-
spond to ﬁ  ve regions of a single protein in the 
fungus Aspergillius nidulans (Lesk, 2001).
To become functionally active, a newly synthe-
sized polypeptide chain must fold a unique three-
dimentional structure. Although experiments 
in vitro have ﬁ  rmly established that the information 
on the three-dimentional structure of a protein is 
genetically determined and contained in its amino 
acid sequence (Anfinsen, 1973; Dobson and 
Karplus, 1999; Nagradova, 2004), protein folding 
in the cell cannot be regarded as occurring sponta-
neously (Nagradova, 2004). It has become clear 
that many proteins require assistance to fold in the 
cell and that this is provided by helper proteins 
(molecular chaperones) (Bukau and Horwich, 1998; 
Coyle et al. 1997; Fewell et al. 2001; Gutsche et al. 
1999; Hartl and Hayer-Hartl, 2002).
The action of chaperones is based on two differ-
ent mechanisms. The ﬁ  rst mechanism consists of 
maintaining the polypeptide chain in a state capable 
of productive folding, which occurs spontaneously 
after release of unfolded chains into solution. 
Thus, interaction with the chaperone has no effect 
on the folding per se (Nagradova, 2004).
The second mechanism is used by chaperons, 
whose large cylindrical complexes create physi-
cally isolated compartments destined for the fold-
ing of polypeptides, partially folded or misfolded 
proteins, which become encapsulated inside the 
central cavity. Since only one molecule of the 
substrate protein can ﬁ  t inside the cavity, its fold-
ing takes place under conditions, which completely 
exclude aggregation (Nagradova, 2004). However, 
the role of chaperons clearly is not limited to their 
ability to create isolated compartments where 
protein can fold spontaneously under condition 
simulating inﬁ  nite dilution (the “Anﬁ  nsen cage” 
model) (Ellis and Hartl, 1996). A large body of 
information accumulated to date supports the 
notion that chaperons can play an active role in 
protein folding, accelerating this process and con-
siderably increasing its efﬁ  ciency (Nagradova, 
2004). A special group of helper proteins so called 
foldases (Balbach, 2000; Wu and Matthews, 2002) 
and protein disulﬁ  de isomerases (Creighton, 2002; 
Frand et al. 2000) assist protein folding by catalyz-
ing the rate-limiting isomerization reactions.
5. Protein splicing
A simple view of protein expression is continually 
challenged by new examples of post-translational 
processing. These examples include non-ribosomal 
addition of moieties and proteolytic cleavage of 
polyprotein as well as excision and rearrangements 
such as intein-mediated protein splicing, splicing 
by reverse proteolysis, protein auto-processing and 
proteasome-mediated peptide ligation (David et al. 
2004; Hanada et al. 2004; Noren et al. 2000; 
Paulus, 2001; Perler, 2005; Perler et al. 1994; 
Vigneron et al. 2004).
a) Intein-mediated protein splicing
Inteins are internal segments of precursor 
proteins that catalyze their ipso excision by an 120
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intramolecular process called protein splicing, 
with the concurrent ligation of the two ﬂ  anking 
external regions (N- and C-exteins) through a 
native peptide bond (David et al. 2004; Perler, 
2005). Inteins are found in proteins of unicellular 
organisms belonging to all three domains of life 
Archaea, Bacteria and Eukarya as well as in viral 
and phage proteins but have not jet been detected 
in higher organisms such as Vertebrata (Hanada 
and Yang, 2005). More than 100 inteins are 
known. Intein host proteins are very diverse, 
including DNA and RNA polymerases, ribonu-
cleotide reductases, ATPases, proteases, meta-
bolic enzymes, transcription and translation 
factors (Pietrokovski, 2001). The following prop-
erties differentiate intein-mediated protein splic-
ing from other types of protein rearrangements: 
(a) intein signature sequence, (b) a self-catalytic 
reaction in the absence of exogenous proteins, 
cofactors or energy sources, and (c) the formation 
of a native peptide bond between the ligated 
exteins (Perler, 2005).
Inteins can be divided into four classes: the maxi 
inteins (with integrated endonuclease domain), 
mini inteins (lacking the endonuclease domain), 
trans-splicing inteins (where the splicing junctions 
are not covalently linked) and Ala inteins (Ala as 
the N-terminal amino acid) (Evans and Xu, 2002). 
The intein speciﬁ  c sequences have some charac-
teristics in common. They appear in conserved 
regions of the host protein. All intein sequences 
harbor different blocks termed A and B at the 
N-terminal splicing domain and F and G at the 
C-terminal splicing domain.
Inteins typically have N-terminal Cys, Ser or 
Ala residues and C-terminal His or Asn and 
inserted into host proteins next to Cys, Ser or Tre 
(Hanada et al. 2004). Although amino acids indi-
cated above are typical for inteins, many inteins 
have other amino acids at speciﬁ  c blocks. It is 
likely that each intein has speciﬁ  c combination of 
nucleophiles and assisting groups honed during 
evolution for optimal function. Structural studies 
have not identiﬁ  ed more consensus facilitating 
residues because each intein has different residues 
with similar chemical functionalities at or near its 
active site (Perler, 2005). The smallest known 
intein consists of 134 amino acids (Evans et al. 
1999), and most are much larger.
The role of inteins in the cell is as yet unclear, 
however, one can assume that because inteins are 
integrated in highly conserved protein regions, the 
function(s) of host protein before and after excision 
of intein might be different. If intein has to excise 
itself for activation the host protein function, it has 
to be sensitive to speciﬁ  c signals. There are some 
indications that this is the case (Chong et al. 1998; 
Southworth et al. 1999). It has been established 
that intein regulates activity of Synechocystis 
sp.PCC6803 DnaE functioning as internal regula-
tor (Ghosh et al. 2001). Free inteins (after splicing) 
may perform regulatory as well as enzymatic func-
tion by itself (Klabunde et al. 1998; Starokadom-
skyy, 2007). Thus, although it has been evidenced 
only in limited number of proteins, inteins may 
determine different functions of host protein before 
and after splicing and to obtain new function(s) 
after self-excision.
b) Post-translational splicing by reverse proteolysis
Another example of post-translational modiﬁ  ca-
tion, protein splicing by reverse proteolysis, is a 
protein splicing discovered in plants. It was 
observed with the lectin concanavalin A (Con A) 
(Carrington et al. 1985). The following steps of 
this kind of protein splicing were described. The 
initial precursor of Con A (glyco-pro-Con A) is 
ﬁ  rst activated by deglycosylation to pro-Con A. 
Pro-Con A is then cleaved to produce two distinct 
proteins that are transposed and relegated to 
become mature Con A. Although the exact mech-
anism of this splicing in plants is still not clear, 
in vitro study showed that asparaginyl endopepti-
dase can digest Con A and then re-ligate the 
digested fragments by its reverse proteolytic activ-
ity (Min and Jones, 1994).
c) Proteasome-mediated protein splicing
Recently it has been shown that proteasomes are 
cell compartments where not only protein degrada-
tion but also post-translational protein modiﬁ  ca-
tions occur (Hanada and Yang, 2005; Hanada et al. 
2004; Vigneron et al. 2004). Hanada et al. (Hanada 
et al. 2004) discovered that antigen maturation and 
presentation may be performed in proteasome by 
protein splicing involving peptide excision and 
re-ligation. They showed that in contrast to intein 
splicing that usually excised polypeptide of not 
less than 134 amino acids in length (the smallest 
known intein is consist of 134 amino acids) the 
excised polypeptides in their system were as short 
as 18–40 amino acids. Using the proteasome 
inhibitor, clasto-lactacystin β-lactone, the authors 121
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evidenced that FGF-5 protein splicing observed in 
their system was proteasome-mediated (Hanada 
and Yang, 2005). Moreover, these authors showed 
for the ﬁ  rst time that protein splicing may occur in 
human cells.
Another group also described an antigen 
production from a protein by splicing of noncon-
tiguous peptides in the reverse order (Vigneron et al. 
2004). This splicing was conducted by 20S protea-
some in vitro and in vivo. In the described systems 
the length of excised intervening region was only 
four amino acids (Noren et al. 2000; Vigneron et al. 
2004). Thus, the proteasome-mediated splicing 
overcomes the limitation associated with the length 
of intervening sequences which is crucial for intein-
mediated protein modiﬁ  cation.
What are the implications of these ﬁ  ndings? 
As Hanada et al. underlined these ﬁ  ndings show 
that “immune system monitors non-contiguous 
peptide sequence generated post-translationally. 
This capability represents an enormous increase 
in the ability of CTLs to recognize self and forein 
proteins… In a broder context, the existence of 
protein splicing in vertebrates greatly increases 
the cell’s options for converting genetic informa-
tion into proteins” (Hanada et al. 2004). These 
results also show that protein splicing is a power-
ful mechanism allowing realization of the 
main principle of protein multifunctionality—
transformation of compact genetic information 
into wide diversity of protein structures and func-
tions. “Processes such as DNA recombination and 
RNA splicing were already known to increase the 
number of different proteins produced by each of 
mammalian genes; the discovery of protein splic-
ing adds to the tool kit” (Rammensee, 2004).
III. Multifunctionality as Intrinsic 
Feature of Different Types
of Proteins
In the previous section we have described some of 
the mechanisms by which the Nature developes 
multifunctionality of the protein molecules. Below, 
we present examples of proteins belonging to dif-
ferent groups that demonstrate high extent of 
multifunctionality.
1. Amino-acyl tRNA synthetases
Amino-acyl tRNA synthetases, an ancient con-
served family of proteins well known for its 
participation in protein synthesis, are a good 
paradigm of protein multifunctionality. Several 
studies have described numerous examples of these 
“housekeeping” proteins taking part in extensive 
critical cellular activities other than protein synthe-
sis. These are cellular ﬁ  delity, cytokine-like activity, 
angiogenesis, RNA splicing, RNA trafficking, 
apoptosis, transcriptional and translational regula-
tion. Amino-acyl tRNA synthetases can even block 
protein synthesis as established by the recent studies 
performed with glutamyl-prolyl-tRNA synthetase 
(Glu-ProRS) (Otani et al. 2002; Sampath et al. 
2004; Wakasugi and Schimmel, 1999).
The lysil-tRNA synthetase (LysRS) has been 
shown to have a dual functionality. In addition to 
its contribution to the translation process, LysRS 
also function as a positive regulator of MITF and 
USF2 transcription factors via the synthesis of 
Ap4A (Lee et al. 2004; Lee and Razin, 2005; 
Plateau and Blanquet, 1982; Yannay-Cohen and 
Razin, 2006; Zamecnik et al. 1966).
Tyrosyl-tRNA synthetase and tryptophanil-
tRNA synthetase upon their release in intracellular 
environment become proinﬂ  ammatory cytokines 
with multiple activities during apoptosis, angio-
genesis and inﬂ  ammation. In addition, these pro-
teins play important role in cancer progression, 
modulation tumor angiogenesis and its escape from 
surveillance by immune system (Ivakhno and 
Kornelyuk, 2004).
2. Cell-surface receptors
a) MUC1 protein
The MUC1 is a mucin-like type I transmembrane 
glycoprotein normally expressed on the surface of 
epithelial, hematopoetic and some other cells 
(Baruch et al. 1997; Weiss et al. 1991; Zaretsky 
et al. 1990). It is generally accepted that MUC1 
gene is transcriptionaly regulated (Zaretsky et al. 
2006; Zaretsky et al. 1999). It is transcribed as a 
single pre-mRNA followed by alternative splicing 
leading to synthesis of isoform speciﬁ  c polypeptide 
chains. Several MUC1 isoforms, MUC1/TM, 
MUC1/X, MUC1/Y, MUC1/Z and MUC1/SEC, 
have been identiﬁ  ed (Tsarfaty et al. 1990; Williams 
et al. 1990; Wreschner et al. 1990; Zrihan-Licht 
et al. 1994). MUC1/TM and MUC1/X are synthe-
sized by translation of alternativly spliced mRNAs 
as single polypeptides that undergo auto-cleavage 
while in the endoplasmic reticulum to yield the 122
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amino-terminal extracellular α-subunit, which in 
case of MUC1/TM contains O-glycosylated 
tandem repeats of 20 amino acids, and the 
carboxyl-terminal β-subunit, containing the mem-
brane anchor (transmembrane domain) and cyto-
plasmic tail (Altschuler et al. 2000; Hilkens and 
Buijs, 1988; Kinlough et al. 2004; Ligtenberg et al. 
1992; Linsley et al. 1988; Litvinov and Hilkens, 
1993; Zrihan-Licht et al. 1994). The resulting 
subunits remain tightly associated with each other 
composing the MUC1/TM and MUC1/X isoforms, 
respectively.
The MUC1/TM and MUC1/X contain the SEA 
domain which is responsible for the self-cleavage 
of the precursor protein molecules leading to 
development of α and β subunits. The MUC1/Y 
isoform also contains SEA domain, however, it 
lakcs of 18 amino acids present in SEA domain of 
the MUC1/X isoform. In contrast to MUC1/X, the 
MUC1/Y is expressed as a single non-cleaved 
nascent polypeptide chain (Levitin et al. 2005b; 
Wreschner et al. 2002).
Translation of the MUC1/Z isoform is associ-
ated with frame shifting (Levitin et al. 2005a). 
The translation initiation of the MUC1 secreted 
form, MUC1/SEC, begins with the same AUG 
codon as other MUC1 isoforms, however, its 
termination stop codon is located in the ﬁ  rst 
intron (Smorodinsky et al. 1996; Wreschner et al. 
1990). The described structural peculiarities of 
MUC1 show its structural diversity which sup-
poses also multiple different functions. Indeed, 
MUC1/TM, MUC1/X and MUC1/Y are expressed 
in plasma membrane and suppose to function as 
membrane receptors which cytoplasmic domains 
participate in different signal transduction path-
ways by interaction with the pathway speciﬁ  c 
transducer molecules (Li et al. 1998; Li et al. 
2003a; Li et al. 2001a; Li et al. 2001b; Li et al. 
2003b; Ren et al. 2002; Singh and Hollingsworth, 
2006; Wen et al. 2003; Wreschner et al. 1994). It 
has been shown that besides participating in 
mucin forming layer, MUC1/SEC functions as 
ligand for MUC1/Y (Baruch et al. 1999). MUC1/
Z demonstrates structural homology with some 
cytokins suggesting participation in defense 
inﬂ  ammation reactions. Recently, it has been 
established that Hkr1 and Msb2, the yeast analogs 
of human transmembrane mucins, are putative 
osmosensors (Tatebayashi et al. 2007). These 
results indicate on possible new function of 
the MUC1.
b) LDL
The members of the low-density lipoprotein (LDL) 
receptor family are evolutionary conserved cell-
surface receptors produced by mammals and other 
organisms (Nykjaer and Willnow, 2002). Initially 
thought to be endocytic receptors that exclusively 
mediate the uptake of lipoproteins (Goldstein, 
2001; Willnow et al. 1994), recent studies in vari-
ous experimental systems including knockout mice 
and patients with receptor gene defects uncovered 
a plethora of additional activities performed by 
these receptors (Gliemann, 1998; Gotthardt et al. 
2000; Herz and Strickland, 2001). The prototype 
of the gene family is the LDL receptor, an endo-
cytic receptor that mediates cellular uptake of 
cholesterol-rich lipoproteins. The LDL receptor 
like other members of this family is built by several 
functionally different domains which may interact 
with numerous of cellular proteins. These domains 
are represented by EGF precursor homology 
domain, complement-type repeat domain, O-linked 
sugar domain and NPxYmotif. Among other mol-
ecules, these domains bind to proteases, protease 
inhibitors, signaling molecules, heat-shock pro-
teins, vitamin carriers, toxins and antibiotics (Basu 
et al. 2001; Gliemann, 1998; Herz and Strickland, 
2001; Howell and Herz, 2001). These receptors 
physiscally or functionally interact with other 
classes of cell-surface proteins such as seven-
transmembrane-span receptors, ion channels, 
glycosylphosphatidylinositol (GPI)-anchored pro-
teins and adhesion molecules, thereby acquiring 
activities not usually observed for endocytic recep-
tors. Binding of ligands not only results in endo-
cytic uptake but also affects many cellular 
functions, including migration, Ca-inﬂ  ux, trans-
cytosis, protein processing, antigen presentation, 
signal transduction, synaptic plasticity and choles-
terol and vitamin homeostasis (Nykjaer and Will-
now, 2002).
3. Proteases
Proteases compose one of the biggest groups of 
proteins. Approximately 2% of mammalian genes 
encode proteases (Kaiserman et al. 2006)[179]. 
Comparative genomics reveals that those involved 
in immunity and reproduction show the most inter-
species diversity and multifunctionality selected 
during evolution. Granzymes, the cytotoxic serine 
proteases used by cytotoxic lymphocytes to destroy 
virus-infected and malignant cells, are the exam-
ples of this protein group.123
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There are 5 granzyme genes in humans and 10 in 
mice, and it is suggested that granzymes have 
evolved through gene duplication. Although high 
sequence homology and conserved primary cleav-
age speciﬁ  city of human and mouse granzymes 
were observed, they are structurally and function-
ally divergent (Bell et al. 2003; Kaiserman et al. 
2006).
Human granzyme B (GrB) has multiple para-
logues in the mouse and rat, suggesting that the 
roles fulﬁ  lled by a single enzyme in humans may 
be split among several in rodents (Pham et al. 1996; 
Revell et al. 2005). Although functioning primarily 
as a cytotoxin, GrB has other roles also. In humans 
it is found in testis and has been implicated in 
reproduction (Hirst et al. 2001). It is also involved 
in extracellular matrix remodeling (Buzza et al. 
2005).
4. Protein kinases
Numerous protein kinases regulate multiple path-
ways of signal transduction. For instance, human 
platelets express at least six protein kinase C (PKC) 
isoforms which phosphorylate multiple proteins 
during platelet activation (Quinton et al. 2002; 
Tsukuda et al. 1988). During hemostasis and 
thrombosis, platelets have two distinct but additive 
functions in thromboformation, aggregation and 
procoagulant activity. Recently, the stimulating and 
inhibitory properties of all PKC isoforms in the 
thrombus-forming process have been studied. It 
was found that platelet PKC isoforms have a dual 
controlling role in thrombus formation as follows: 
(1) by mediating secretion and integrin activation 
required for platelet aggregation under blood ﬂ  ow, 
and (2) by suppressing Ca
2+-dependent phospha-
tidylserine exposure, and consequently thrombin 
generation and coagulation. Thus, platelet PKC is 
the signaling protein that balances the pro-
aggregatory and procoagulant functions of thrombi 
(Strehl et al. 2007).
5. Cholinesterases
Cholinesterases A and B, AChE and BChE, are two 
enzymes which classical roles are “cholinergic 
functions” that originate from their cholinolytic 
capacity (Layer et al. 2005). However, recently 
non-classical functions of these enzymes have been 
uncovered (Johnson and Moore, 2004; Layer et al. 
1993; Paraoanu and Layer, 2004). A high degree 
of sequence homology between AChE and a family 
of synaptic cell adhesion proteins, e.g. neuroligins, 
suggested that AChE may act also as a heterophilic 
cell adhesion molecule. Indeed, AChE was found 
to bind laminin-β1, an extracellular matrix protein 
involved in neuronal differentiation and adhesion. 
AChE binds to the laminin-β1 chain and through 
it can activate integrin receptor which in its turn 
activates intracellular signaling pathways. Thus, 
the complexing of AChE with laminin-1 represents 
a major signaling mechanism of AChE in cell 
formation process and pathﬁ  nding (Layer et al. 
2005).
Besides of the described functions, both types 
of cholinesterases exhibit also aryl acylamidase 
activities (called AAA-AChE and AAA-BChE, 
respectively), which have been suggested to be 
involved in developmental processes (Layer et al. 
2005).
6. Deglycosylation enzymes
Deglycosylation enzemes represents of group of 
proteins that catalyze separation of peptide com-
ponent of glycoprotein from its carbohydrate part. 
As a paradigm of polyfunctional member of this 
group we chose the peptide: N-glycanase (PNGase). 
PNGase releases intact N-glycans from misfolded 
glycopeptides or glycoproteins which undergo 
deglycosylation during their degradation (Suzuki 
et al. 2002; Suzuki et al. 2007). The PNGase is a 
member of the transglutaminase (TGase) super-
family (Makarova et al. 1999). The orthologues of 
this enzyme are widely distributed throughout 
eukaryotes. While the “core” TGase domain is well 
conserved, a key difference is that orthologoues in 
higher eukaryotes have additional domains at both 
N- and C-termini of the core domain. The PNGase 
of S. cerevisiae contains only TGase/PNGase 
domain, while C. elegans enzyme in addition to 
TGase domain has thioredoxin domain and 
Man-binding domain located N- and C-terminally, 
respectively. S. cerevisiae possesses only deglyco-
sylation activity whereas PNGase from S. elegans 
exhibits dual enzyme functions, not only as 
PNGase but also as an oxidoreductase (thiore-
doxin). Thus, structural changes associated with 
additional domains exhibited additional function 
to modiﬁ  ed molecule.
7. Growth factors
Growth facrors are typically multifunctional pro-
teins. Two examples will illuctrate this notion. 124
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FGFs are heparin-binding multifunctional growth 
factors which play a crucial role in a variety of 
developing processes (Bohlen, 1989). FGF-2 is 
one of the currently known members of the ﬁ  bro-
blast growth factor family. It has been established 
that FGF-2 functions as 1) a differentiation factor 
for sympathoadrenal progenitor cells; 2) a target-
derived neurotrophic factor for the preganglionic 
sympathetic neurons of the spinal cord and 3) an 
element of the auto-/-paracrine chain in the adrenal 
medulla (Grothe and Meisinger, 1997).
Growth-colony stimulating factor (G-CSF), 
named for its speciﬁ  c stimulation of the growth 
of neutrophil progenitor cells in vitro (Roberts, 
2005), is a growth factor known as a major extra-
cellular regulator of haemopoesis and innate 
immune system. G-CSF inﬂ  uences the survival, 
proliferation and differentiation of all cells in the 
neutrophil lineage, from haemopoetic stem cell 
to mature neutrophils. Recent researches uncov-
ered initially unsuspected polyfunctionality for 
G-CSF. This growth factor is well recognized now 
as a signaling molecule as well as mobiliser of 
haemopoetic stem cells from bone marrow into 
the blood. Beside that G-CSF inﬂ  uences T-cell 
function and dendritic cell activation (Roberts, 
2005).
8. Cytokines/chemokines
Chemokines are small cytokines that function in 
immune responses, wound healing, inﬂ  ammation 
and tumorogenesis (Sorg, 1989). This multifunc-
tionality has been attributed primarily to ligand 
interaction with multiple receptors. Recent stud-
ies have shown that their multifunctionality could 
also result from interactions of the receptors with 
small peptides produced by precessing of the 
chemokines. Li et al. (Li et al. 2004) have ana-
lyzed the interactions between the two forms of 
human interleukin 8 (hIL8), N- and C-peptides, 
with the chemokine receptors hCXCR1 and 
hCXCR2 and showed that the N and C termini of 
the chemokine could stimulate the respective 
CXCR1 to induce intracellular Ca
2+ release and 
MAPK activation independent of the other 
regions of molecule. These peptides could also 
stimulate chemotaxis of several cell types and this 
function is speciﬁ  c and mediated by hCXCR1 
and/or hCXCR2. These ﬁ  ndings advance under-
standing of the multifunctionality exhibited by 
chemokines.
9. Growth hormone
The growth hormone (GH) is a large multifunc-
tional protein. It exhibits extensive heterogeneity. 
Some GH molecules/fragments are generated and 
secreted directly from the pituitary gland without 
any post-translational modiﬁ  cation, whereas other 
molecules or fragments do arise from post-synthetic 
modiﬁ  cations (De Palo et al. 2006; Lewis et al. 
2000; Wood, 2001). The link between molecular 
structures (different fragments of the GH-
molecule) and biological effects were studied and 
analysis of functional activities possessing by dif-
ferent fragments of the GH molecule conﬁ  rmed 
this statement.
It has been shown that the GH1-43 a.a. fragment 
possesses an important insulin-like activity, but 
does not appear to have growth-promoting activity.
The insulin-like action of this amino-terminal seg-
ment has been conﬁ  rmed in a series of GH peptide 
fragments including GH1-20 a.a., GH1-15 a.a. and 
GH6-13 a.a. All these GH fragments have been 
demonstrated to induce hypoglycaemia in vivo and 
amplify the actions of insulin in vitro (Ohkura and 
Hori, 2000).
GH44-191 a.a. fragment demonstrates neither 
growth-promoting nor insulin-like activities. On 
the contrary, it possesses GH antagonist activity 
(Clerico et al. 2000; Heffernan et al. 2000). 
GH108-129 a.a. fragment appears to possess mito-
genic activity although intact GH demonstrates 
anti-mitogenic activity (De Palo et al. 2006). These 
data evidently demonstrate that different domains 
of the same protein molecule possess different and 
sometimes opposite functions.
10. Lactoferrin
Lactoferrin, a component of mammalian milk, is 
a member of the transfer proteins family (Brock, 
2002; Kanyshkova et al. 2001). These glycopro-
teins transfer Fe
3+ ions (Brock, 2002; Suzuki and 
Lonnerdal, 2002). Lactoferrin is a polyfunctional 
protein that inﬂ  uences cell proliferation and dif-
ferentiation (Baveye et al. 1999). It regulates also 
granulopoiesis and DNA synthesis. Lactoferrin 
inhibits prostaglandin synthesis in human milk 
macrophages and activates the nonspeciﬁ  c immune 
response by stimulating phagocytosis and comple-
ment (Baveye et al. 1999; Mann et al. 1994; Ward 
et al. 2002). It interacts with macromolecules such 
as DNA, RNA, proteins, polysaccharides and 
heparin-like polyanions (Elass-Rochard et al. 125
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1995; He and Furmanski, 1995; Son et al. 2002). 
In some cells lactoferrin functions as transcription 
factor (He and Furmanski, 1995; Mariller et al. 
2007). It was recently demonstrated that lactofer-
rin also possesses ribonuclease activity (Kanyshkova 
et al. 2001).
11. Protein synthesis regulatory proteins
Protein synthesis regulatory proteins as well as 
proteins of other groups demonstrate extensive 
polyfunctionality. Sometimes, the functions they 
possess are unrelated or even opposite. As a para-
digm of these proteins we will discuss the iron 
regulatory protein 1 (IRP1). IRP1 is a cytosolic, 
RNA binding protein that regulates the translation 
and stability of mRNAs encoding proteins for iron 
transport, storage, and use (Walden et al. 2006). 
IRP1 has an alternate function as cytosolic 
(c)-aconitase when the iron sulfur [4Fe-4S] cluster 
is bound (Eisenstein, 2000; Henderson and Kuhn, 
1995; Hentze and Kuhn, 1996; Hentze et al. 2004; 
Kennedy et al. 1992; Theil and Eisenstein, 2000). 
The distribution of IRP1 between these mutually 
exclusive functions requires no new protein syn-
thesis; iron excess promotes (c)-aconitase activity 
while starvation activates RNA binding function 
(Henderson and Kuhn, 1995). Assembly and disas-
sembly of the iron-sulfur cluster appears to be 
effective mechanism for regulation IRP1 activity, 
dependnt on facile interchange between the two 
functional conformations.
The RNA-binding and enzyme active sites are 
extensively overlapped in IRP1, with many amino 
acids serving important, but different, roles in each 
functional state of the protein. The functional 
plasticity of amino acids serving both catalytic and 
RNA binding roles reﬂ  ects the conformational 
ﬂ  exibility of the protein, particularly in the vicin-
ity of the Fe-S and RNA binding sites (Walden 
et al. 2006).
12. Transcriptional factors
Proteins regulating transcription belong to a huge 
group of DNA binding proteins. Zinc-ﬁ  nger con-
taining proteins represent one of the subgroups of 
these proteins. The WT1, zinc-ﬁ  nger containing 
transcription factor, is a multifunctional protein. 
Two allels of WT1 gene is described: one contains 
insertion of three amino acids (+KTS) immediately 
after the zinc-ﬁ  nger 3b and another which does not 
contain this insertion (−KTS). In its transcriptional 
roles the WT1(−KTS) acts as an activator (Lee et al. 
1999) while WT1(+KTS) functions as a repressor 
of transcription (Loeb et al. 2002). The WT1(−KTS) 
also binds RNA and interacts with SF1 (steroido-
genic factor nuclear hormone receptor). On the 
contrary, the WT1(+KTS) weakly interact with SF1 
but strongly binds to U2snRNP-associated splice 
factor (Ladomery and Dellaire, 2002).
Another zink-finger protein coding gene, 
ZNF74, can produce multiple protein isoforms 
through alternative promoter usage and splicing: 
these exhibit differences in their transcriptional 
activities and nuclear partitioning (Cote et al. 
2001). The original isoform, ZNF74-I, lacks the 
canonical N-terminal sequences of KRAB box A, 
localizes to speckle domains and exhibits weak 
transcriptional repression. In contrast to this, the 
ZNF74-II isoform contains the full KRAB A and 
B boxes, exhibits strong transcriptional repression 
and localizes in a diffuse pattern throughout the 
nucleus (Ladomery and Dellaire, 2002).
The presented data show that these and probably 
other Zn-ﬁ  nger proteins possess functional versi-
tality of the zinc ﬁ  nger motif and suggest that both 
alternative splicing and sub-cellular compartmen-
talization may modulate their multifunctionality.
13. Bacterial toxins
Bacterial toxins represent interesting examples of 
protein multifunctionality. Many toxins that act 
intracellularly have multidomain organization, 
with each domain capable of mediating a separate 
step of the intoxication process. There are numer-
ous different mechanisms by which a bacterial 
toxin can produce pleiotropic cellular effects. On 
the basis of their ability to cause pleotropic cel-
lular effects, bacterial toxins may be regarded as 
multifunctional proteins (Cover and Blanke, 
2005).
Two of the most extensively studied examples 
of multifunctional bacterial toxins are ExoS and 
ExoT from Pseudomonas aeruginosa. These toxins 
have multiple effector domains, each of which is 
associated with a discrete activity against the host 
cell. The N-terminal domains of ExoS and ExoT 
are GTPase-activating proteins (GAPs) that target 
members of the Rho family of small GTPases, 
which regulate processes in cytoskeleton (Goehring 
et al. 1999). The C-terminal domains are ADP-
rybosyltransferases that modify multiple host 
proteins, including Ras and Ras-like GTPases 126
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(Vincent et al. 1999). The discrete effector domains 
of these toxins may retain functional activity if 
expressed as individual proteins. The RhiGAP 
activities of EXoS and ExoT are almost identical, 
whereas ExoS and ExoT ADP-ribosylation effects 
are directed to different substrates (Barbieri and 
Sun, 2004).
Another example of a multifunctional toxin is 
the binary toxin produced by Bacillus anthracis. 
The B subunit of this toxin (protective antigen) can 
translocate two different A subunits into host cells. 
The A subunits may function as a metalloprotein-
ase known as lethal factor or as adenylate cyclase 
known as oedema factor. On entry into host cells, 
lethal factor can cause many different effects, 
including alteration of dendritic-cell functions, 
repression of glucocorticoid-receptor transactiva-
tion, lysis of macrophages and apoptosis (Agrawal 
et al. 2003; Friedlander, 1986; Kirby, 2004).
The VacA toxin of Helicobacter pylori also 
possesses multiple functions producing upon entry 
into the cell: alterations in late endosomes, altera-
tions in mitochondrial membrane permeability and 
inhibition of T-cell proliferation (Cover and 
Blanke, 2005).
Thus, many bacterial toxins are multifunctional 
proteins. By producing toxins with multifunctional 
properties, bactera are able to use a single protein 
to produce a range of effects at different sites in 
the host, depending on which cell types and tissues 
are targeted. Consolidating multiple functions 
within a single protein has several advantages to 
the bacteria, including conservation of genome 
space, conservation of energy and resources that 
would be needed to regulate, produce and secrete 
multiple gene products, and stoichiometric, special, 
and temporal control of multiple host-modulating 
activities.
14. Plant ABC transporters
The ABC-transporter superfamily is one of the 
largest protein families known. Its members can 
be found in bacteria, fungi, plants and animals 
(Henikoff et al. 1997; Martinoia et al. 2002). All 
ABC transporters consisit of two pairs of basic 
structural elements: integral membrane-spanning 
domains and nucleotide-binding folds oriented 
towards the cytoplasm. In bacteria, most members 
of this family are responsible for the high-afﬁ  nity 
uptake of small molecules (for example, maltose 
and histidine) (Higgins, 1992). Eukaryotic ABC 
transporters mediate diverse cellular transport 
processes, such as excretion of potentially toxic 
compounds, lipid translocation, excretion of the 
mating factor of yeast, conferring heavy-metal 
tolerance, multidrug resistance, and antigen pre-
sentation, as well as exhibiting ion channel activ-
ity (Balzi and Goffeau, 1994; de Souza et al. 2000; 
Gottesman and Pastan, 1993; Higgins, 1995; 
Kelly et al. 1992; Kuchler et al. 1989; McGrath 
and Varshavsky, 1989; Szczypka et al. 1994). The 
ﬁ  rst reports on plant ABC transporters showed 
that they are implicated in detoxiﬁ  cation pro-
cesses. Recent results indicate that the function 
of this protein family is not restricted to detoxi-
ﬁ  xation. Plant ABC transporters have been dem-
onstrated to participate in chlorophyll 
biosynthesis, formation of Fe/S clusters, stromal 
movement and ion ﬂ  uxes. They may also transport 
steroids and participate in signal transduction. 
Hence, plant ABC transporters play multifunc-
tional central role in plant growth and develop-
ment (Higgins, 1992).
“Hidden” protein functions
The list of the multifunctional proteins is not lim-
ited to the described examples and could be 
extended. The multifunctionality appears to be a 
general feature of proteins. It is most likely, that 
in cases where proteins exhibit monofunctionality, 
the other functions of a protein have simply not jet 
been identiﬁ  ed. These are “hidden” functions.
The “hidden or eclipsed” function is not a rear 
phenomenone. Many causes may lead to situation 
when one or several protein isoforms can not be 
detected while they were synthesized and present 
in the cell. One such a cause is a very short half-life 
time of some mRNA and/or protein. Another cause 
is the efﬁ  ciency of the mRNA detection methods. 
The generally used analysis of expressed sequence 
tags (ESTs) is not perfect because the EST collec-
tion does not represent all protein coding sequences 
and for most genes ESTs cover only a portion of 
the transcripts. For instance, only half of the genes 
located on human chromosome 22 are represented 
in the current EST database (Dias Neto et al. 2000). 
Moreover, 26% and 65% of the ESTs correspond 
to the extreme 5’ and 3’ ends, respectively, of any 
given transcript (Graveley, 2001; Regev-Rudzki 
and Pines, 2007). Because much of the functionally 
signiﬁ  cant alternative splicing occurs in the coding 
region of the transcript, many alternative splicing 127
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events might be overlooked by EST comparisons 
(Graveley, 2001).
Speaking about the causes leading to “loss of 
protein functions”, one should consider the phe-
nomenone of dual- or multi-targeting of proteins 
and its consequence. The precise subcellular 
localization of a protein is ctitical for its function. 
Eukaryotic cells synthesize thousands of proteins, 
each having a speciﬁ  c function in a speciﬁ  c subcel-
lular compartment. In recent years, a growing 
number of examples of single genes whose prod-
ucts are located to two (or more) separate compart-
ments have been discovered (Huh et al. 2003; 
Karniely and Pines, 2005; Mackenzie, 2005).
There is a growing number of studies designed 
to develop a global screens of protein localization 
in order to characterize location-speciﬁ  c function 
(Kumar et al. 2002; Regev-Rudzki et al. 2005; 
Yook et al. 2004). However, these “large-scale” 
analyses often fail to detect one of the isoproteins 
in one of the locations of a dual targeted protein 
due to a highly uneven distribution between com-
partments. In frame of this phenomenon called by 
N. Regev-Rudzki and O. Pines ‘eclipsed distribu-
tion’ (Regev-Rudzki and Pines, 2007), the rela-
tively large amount of an isoprotein in one 
subcellular compartment obscures the detection of 
the small amount of the other isoprotein in the 
other location (Levay and Viljoen, 1995).
As underlined by Regev-Rudzki and Pines 
(Regev-Rudzki and Pines, 2007), ‘such eclipsed 
distribution phenomena have a wider occurance 
than recorded currently; the reason being that, in 
most cases, the small fraction of one of the isopro-
teins, in one of the locations, makes its detection 
very difﬁ  cult. This is particularly true for the cyto-
sol which occupies several fold larger volume than 
other compartments thus diluting a signiﬁ  cant 
amount of a dual targeted protein, so that it is eas-
ily missed by the currently used large-scale visu-
alization methods’.
Conclusion
The data presented in this review evidently show 
that genetic information embedded in nucleotide 
sequences of a genome contains a program of 
multiple structural and functional transformations 
of this information into real protein molecules that 
are involved in mirriads of reactions which ulti-
mately determine physiology of a cell. Moreover, 
the encoded physico-chemical potentials of the 
molecules allows intermolecular interactions in 
such a way that one molecules may modify the 
other molecules thus increasing structural and 
functional diversity of the proteins produced by a 
given gene. After all, thousands of protein mole-
cules that build the multiple mechanisms respon-
sible for protein synthesis and different 
post-translational modiﬁ  cations are encoded in a 
compact form in cell genome. Hence, the cell may 
be considered as a very economic self-coding and 
self-realizing system which effectivity is beeing 
achieved by usage of multifunctional protein mol-
ecules. Thus, the multifunctionality is not an 
exceptional feature of a particular protein but to 
the contrary it is a fundamental basic property of 
most or all proteins which allows the cell effective 
accomplishment of multiple and complex physi-
ological processes.
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